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ABSTRACT

NEURONAL GQ STRUCTURES IN NEURODEGENERATION

By
Damian S. McAninch
August 2017

Dissertation supervised by Dr. Mihaela-Rita Mihailescu
This study investigates protein nucleic acid interactions between various proteins and G
quadruplex (GQ) forming messenger RNAs (mRNAs) in human neurological disorders. GQ
structures are formed in DNA/RNA, when four guanine residues form planar tetrads stabilized by
Hoogsteen base pairing, that stack forming a GQ structure stabilized by potassium ions. These GQ
structures are targeted by the arginine-glycine-glycine (RGG) repeat domain containing RNAbinding domain.
Three RGG domain containing RNA-binding proteins, all of which have been implicated
in neurological disorders, and their interactions with GQ forming mRNAs, were investigated in
this study: fused in sarcoma (FUS), fragile X mental retardation protein (FMRP), and hnRNP Q1.
Initially we analyzed the interactions between FUS and two neuronal GQ forming mRNAs,
Shank1 and PSD-95 mRNAs. Our results indicate that FUS binds these GQ structures with high
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affinity and specificity. This is the first study showing that FUS recognizes the GQ RNA structure
in neuronal mRNA targets, suggesting a role for localization of the mRNA to the synapse. FMRP,
whose loss of expression leads to the fragile X syndrome, is a translation regulator that has been
shown to bind to GQ mRNA structures. Here we identified another FMRP GQ forming mRNA
target, SMNDC1 mRNA, and characterized its interactions with FMRP. FUS has also been
implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) and more
recently it has been shown that an expansion of (G4C2) repeats within the C9ORF72 is causative
of ALS/FTD. We and others have shown that these repeats form GQ structures and here we
demonstrate that both FMRP and FUS bind these repeats, suggesting a possible mechanism by
which the repeat expansion leads to the sequestration of RNA binding proteins. Finally, we
demonstrate that hnRNP Q1, a protein involved in mRNA processing, recognizes a GQ structure
in GAP43 mRNA. This study increases our understanding of the biological functions of the mRNA
GQ structure and of their role in neurodegenerative diseases.
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Chapter 1: Fused in Sarcoma Targets Neuronal GQ forming mRNA
Chapter 1.1 Introduction. Fused in sarcoma (FUS), identified as the heterogeneous nuclear
ribonuclear protein P2, belongs to the family of proteins consisting of FUS, Ewing’s Sarcoma, and
TATA-binding protein associated factor 15 (FET). The FET family is predominantly localized to
the nucleus and highly expressed in all examined tissues (Andersson et al. 2008, Morohoshi et al.
1996, Zinsner et al. 1994). Each of the FET proteins contains an RNA recognition motif (RRM),
arginine-glycine-glycine repeat (RGG) regions, and a Cys2-Cys2 zinc finger (Tan and Manley
2009, Iko et al. 2004). Specifically, FUS has a low-complexity prion like domain, three RGG
regions, an N-terminal region with transcriptional activating properties, and a C-terminal region
capable of binding DNA, RNA, and splicing factors (Figure 1A) (Law et al. 2006). Nuclear FUS
shuttling is facilitated by its C-terminal proline-tyrosine nuclear localization signal (NLS) and
methylation of its C terminal RGG domain (RGG3 domain) (Dormann et al. 2012, Lee et al. 2006).

Figure 1. Diagram of the FUS domains and Shank1a/PSD-95 structures. A) FUS contains a
SYQG rich region, an RNA recognition motif and three arginine-glycine-glycine (RGG)
domains. B) Predicted structure of Shank1a GQ and PSD-95 GQ2 (Stefanovic et al. 2014, Zhang
et al. 2014). C to U mutations indicated with arrows, and 2AP substitutions denoted by circled
position.
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In the nucleus, FUS affects transcription through protein-protein interactions with RNA
polymerase II, the TATA-binding protein, and the TFIIIB transcription factor (Powers et al. 1998,
Tan and Manley 2009). Interactions with the spliceosome machinery supports a co-transcriptional
and/or pre-mRNA splicing regulatory role of FUS (Hartmuth et al. 2002, Rappsilber et al. 2002,
Zhou et al. 2002, Yu and Reed 2015). One study showed that around 1,000 mRNAs had altered
splicing patterns or abundance in a FUS-dependent manner in mouse brain (Lagier-Tourenne et
al. 2012), supporting the role of FUS in mRNA regulation. Transcription and mRNA processing
are among the many nuclear functions of FUS (Aman et al. 1996, Calvio et al. 1995, LagierTourenne et al. 2010, Tan and Manley 2009), however, studies have revealed that FUS functions
outside of the nucleus as well. FUS has been observed within neurophil granules (Aoki et al. 2012),
clustered in the post-synaptic density of rat hippocampus and co-localized with marker SYP1
(Schoen et al. 2016). Mouse studies suggest that synapses are significantly more susceptible to
defects than axons and cell bodies when FUS is overexpressed or mutated (Sephton et al. 2016),
indicating that FUS is important for synaptic plasticity and maintenance. mGluR activation causes
the translocation of FUS to the dendrite (Fujii et al. 2005), strongly suggesting a role as a synaptic
RNA-binding protein for mRNA transport and translation regulation at the dendrite (Aokii et al.
2012, Fujii et al 2005, Liu-Yesucevitz et al. 2011). This would affect synaptic plasticity and
maintenance, which may explain abnormal spine density and morphology in FUS knockdown mice
(Fujii et al. 2005, Sephton et al. 2016).
Though nuclear FUS targets have been identified based on clip studies (Hoell et al. 2011,
Ishigaki et al. 2012), the mechanisms by which FUS functions outside of the nucleus has yet to be
elucidated. In a human genome-wide approach, more than 5,500 in vivo RNA targets were
discovered for FUS (Lagier-Tourenne, et al.2012). FUS binding primarily occurs near the 3’ end
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of introns and the 3’ untranslated regions (UTR), coating the mRNA similar to histones binding
DNA (Kato et al. 2012). FUS can target GU rich sequences using all three RGG domains and its
RRM; RGG domains 2 and 3, alone, aid in alternative splicing in vivo (Iko et al. 2004, Lerga et al.
2001). Additionally, secondary structural elements can be targeted: hairpin structures with UU or
UC pairing at the base of the loop (Hoell, et al. 2011), G quadruplex (GQ) forming human telomere
DNA, and a telomeric repeat containing RNA are bound by FUS (Takahama et al. 2013). These
GQ structures are targeted solely by the C-terminal RGG (RGG3) domain (Takahama et al. 2013).
GQ structures are formed when four guanine residues assemble into a planar G-quartet through
Hoogsteen base pairing, stabilized by a central potassium ion, with several of these G quartet stacks
forming a GQ (Sen and Gilbert 1990, Hud et al. 1996).
Translation regulation can often be facilitated in RNA granules, where mRNA can be
stored for transport to specific cytoplasmic regions, such as the dendrite (Knowles et al. 1996,
Mahowald 1962), or under cellular stress conditions. Immediate redistribution of FUS from the
nucleus to the cytoplasm where it was incorporated into stress granules was observed under
hyperosmolar stress (Sama et al. 2013). Hydrogel droplets composed of the low complexity prion
like domain of FUS were generated to mimic the formation of FUS containing RNA granules,
yielding 11 enriched mRNAs (Han et al. 2012). Two neuronal mRNAs involved in synaptic
plasticity and maintenance, Shank1 and postsynaptic density protein 95 (PSD-95), were among
the 11 mRNAs found enriched in FUS hydrogels (Han et al. 2012) and are thought to enter RNA
granules (Muddashetty et al. 2007, Bockers et al. 2004). Shank1 belongs to the Shank family of
proteins, which regulate the size and shape of dendritic spines by binding various components of
the post synaptic density (Boeckers et al. 2002). PSD-95 is a member of the membrane-associated
guanylate kinase family and is a postsynaptic scaffold protein essential for glutamate receptor
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localization and synapse function (Keith and El-Husseini 2008). Therefore, the regulation of both
Shank1 and PSD-95 mRNAs would be vital for neuronal health.
Both Shank1 and PSD-95 mRNAs are targets of the fragile X mental retardation protein
(FMRP), whose loss of expression leads to the fragile X syndrome (Muddashetty et al. 2011,
Schütt et al. 2009, Stefanovic et al. 2014, Zhang et al. 2014). Interestingly, Sephton et al. notes
that FUS regulation at the synapse somewhat parallels FMRP’s (Sephton et al 2016). FMRP, like
FUS, responds to mGluR activation and affects dendritic spine shape by regulating local
translation of mRNAs at the synapse (Darnell and Klann 2013). Autism-like symptoms in
individuals with fragile X mental retardation syndrome are thought to be caused by mutations in
the FMR1 genes, resulting in the loss of FMRP function in spine maturation (Irwin et al. 2013).
FMRP uses its RGG domain to bind GQ structures formed in mRNA targets (Darnell et al. 2001,
Blice-Baum and Mihailescu 2013, Evans and Mihailescu 2014, Stefanovic et al. 2014, Stefanovic
et al. 2015, Zhang et al. 2014). Since FUS RGG3 domain has been shown to bind telomeric DNA
and telomeric repeat containing RNA, it is possible that FUS could also target neuronal mRNA
GQ structures. Our lab has shown that two neuronal mRNAs found enriched in FUS hydrogels
and components of the post synaptic density, Shank1 and PSD-95 mRNAs, form GQ structures in
their 3’ UTRs that are targeted by FMRP (Stefanovic et al. 2014, Zhang et al. 2014). Given FUS’s
regulatory role at the synapse and the fact that it contains RNA binding domains which have been
shown to bind a telomeric RNA GQ structure, we hypothesized that FUS recognizes GQ forming
sequences formed in the 3’UTR of some of its neuronal mRNA targets. In this study, we found
that FUS binds the GQ structures formed in the Shank1 and PSD-95 mRNA 3’-UTRs with
nanomolar dissociation constants and that the GQ structure alone is sufficient for recognition.
These results suggest a novel mechanism of GQ binding and mRNA regulation at the synapse by
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FUS, warranting additional studies exploring the role of FUS in the regulation of the transport,
stability and translation of Shank1 or PSD-95 mRNAs.

Chapter 1.2 FUS C-terminal RGG motif recognizes GQ RNA sequences specifically.
We have demonstrated that two of the potential mRNA targets of FUS that are important for
synaptic plasticity and maintenance, Shank1 and PSD-95 mRNAs, contain GQ structures in their
3’-UTRs (Stefanovic et al. 2014, Zhang et al. 2014). Only one of the two Shank1 GQs we
characterized, named Shank1a (Zhang et al. 2014), is conserved in mammals and was therefore
used in subsequent experiments in this study. Two GQ structures were identified in PSD-95
mRNA, GQ1 and GQ2, but only GQ2 (Figure 1B) was chosen for further analysis in this study
since it forms a single conformation, while GQ1 is dynamic, forming alternate conformations
(Stefanovic et al. 2014). Since FUS RGG3 was the only FUS motif capable of binding the GQ
structure in a study by Takahama et al. (2013), we initiated this project by using a peptide
composed of the FUS RGG3 domain (amino acids 448-526). Native polyacrylamide gel
electrophoresis (PAGE) was used to demonstrate binding of FUS to Shank1a GQ and PSD-95
GQ2 (Figure 2).

Figure 2. FUS binds shank1a GQ and PSD-95 GQ2. 20% Native PAGE, 88 volts, 4°C for 4
hours. The gel was visualized by UV-shadowing. A) Wild type PSD-95 GQ2 RNA (lane 1) in
the presence of increasing FUS RGG3 concentrations (lanes 2-4). B) Wild type Shank1a GQ
(lane 1) in the presence of increasing FUS RGG3 concentrations (lanes 2-4).
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Table 1. RNA and peptide sequences used in this study. Guanines involved in GQ formation
are underlined, fluorescent analogues are in bold, and † indicates mutated nucleotides.

FUS RGG3 has 19 positively charged amino acids and given the short sequence lengths of the
GQs investigated (Table 1), the formed complex will have an overall positive charge and will not
migrate through the gel. Thus, complex formation is monitored by the disappearance of the free
RNA band. As seen in figure 2A which shows the binding of FUS RGG3 to PSD-95 GQ2, the free
RNA band (lane 1) diminishes significantly when the peptide is added in a 1:1 ratio (lane 2), and
is no longer observed at 1:3 ratio (lane 4). A similar trend is observed for the binding of FUS
RGG3 to Shank1a GQ (Figure 2B), leading us to conclude that the FUS RGG3 motif binds both
Shank1a GQ and PSD-95 GQ2 RNA structures.
FUS was shown to bind telomeric DNA and RNA GQ structures specifically over the
single stranded and helix conformations (Takahama et al. 2013), but up to this point FUS has not
been shown to bind neuronal GQs. Here we demonstrate for the first time, direct interactions
between the FUS RGG3 domain and neuronal GQ forming mRNA. However, FUS has been shown
to target other secondary structures as well. Specifically, FUS can bind GU rich sequences using
all three RGG and RRM domains with its RGG domain 2 and 3 aiding in E1A alternative splicing
(Lega et al. 2001). A hairpin structure with UU or UC as the first base pair in the loop and a
conserved GGUG sequence were additionally shown to be targeted by FUS (Hoell et al. 2011).
Though Shank1a GQ and PSD-95 GQ2 sequences do not show evidence of hairpin formation
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(Stefanovic et al. 2014, Zhang et al. 2014), the RNAs contain GGUG in both sequences (Figure
1B), which may be targeted by FUS.
To determine if the GQ structure per se is sufficient for the FUS recognition, we mutated
the GGUG stretches to GGCG in both Shank1a GQ and PSD-95 GQ2 in such a way that their
ability to form GQ structures was not impacted (arrows in Figure 1B). One-dimensional (1D) 1H
NMR spectroscopy experiments were performed to examine the preservation of the GQ, by
monitoring guanine imino proton resonance region between 10-12 ppm (Fürtig et al. 2003).
Spectra were acquired for both Shank1a GQ mutant and PSD-95 GQ2 mutant in the absence and
presence of 150 mM KCl (Figure 3A and 3B).
Even in the absence of KCl, resonances were observed between 11-12 ppm for the PSD95 GQ2 mutant and centered around 11 ppm for the Shank1a mutant (Figure 3A). Upon addition
of KCl, resonances centered around 11 ppm were stabilized for both RNAs. Shank1a GQ spectra
also depicted resonances between 12-14.5 ppm indicative of Watson-Crick base pairing in the
presence and absence of KCl. When folded with the RNA structure software (Reuter and Matthews
2010) the mutated Shank1a GQ containing the U to C point mutation was predicted to form a
bimolecular structure stabilized by Watson-Crick base pairing in the center (Figure 4). Thus, the
1

H NMR spectroscopy data showed that the mutated PSD-95 GQ2 retains the ability to form GQ,

whereas the mutated Shank1a forms a GQ structure in equilibrium with a bimolecular
conformation stabilized by Watson-Crick base pairing. We noted that the predicted bimolecular
structure has overhanging single stranded G rich regions that could also form GQ structures
(Figure 4).
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Figure 3. Characterization of mutant Shank1a GQ and PSD-95 GQ2. 1H NMR spectra of A)
Shank1a GQ mutant and B) PSD-95 GQ2 mutant. Both sequences contain imino proton
resonances between 10-12 ppm indicative of GQ formation. Shank1a GQ mutant also contains
imino proton resonances corresponding to Watson-Crick base pairs as it forms a bimolecular
structure (Figure 4). CD spectra of C) Shank1a GQ mutant and D) PSD-95 GQ2 display a
positive band at 265 nm and a negative band at 240 nm, indicating that the parallel GQ fold was
maintained for both sequences. UV-thermal denaturation profiles were obtained for E) Shank1a
GQ mutant and F) PSD-95 GQ2 mutant. Shank1a GQ mutant was denatured in the presence of
2.5 mM KCl and 10 mM cacodylic acid, pH 6.5. PSD-95 GQ2 mutant was denatured in the
presence of 1 mM KCl and 10 mM cacodylic acid, pH 6.5. Hypochromic transitions were fit
using equations 1 and 2 (materials and methods), assuming a two-state model.
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Figure 4. Bimolecular Shank1a mutant structure. Shank1a mutant is predicted to adopt a
bimolecular structure, stabilized in the center by Watson-Crick base pairs and flanked on either
side by single stranded sequences that adopt a GQ structure.

Both wild-type Shank1a GQ and PSD-95 GQ2 form parallel GQ structures (Stefanovic et
al. 2014, Zhang et al. 2014). CD spectroscopy experiments were performed in the presence of
increasing KCl concentrations to determine if the mutants retained the parallel GQ fold. In the
absence of KCl, a negative band at 240 nm and a positive band at 265 nm were observed for
Shank1a GQ and PSD-95 GQ2, indicative of a parallel fold (Figure 3C and 3D) (Ðapić, V. et al.
2003, Williamson, J.R. 1994). The band intensity at 265 nm increased upon addition of KCl to
PSD-95 GQ2, indicating the further stabilization of its GQ structure by K+, while the band intensity
at 265 nm for Shank1a GQ was unaffected by increasing KCl concentration.
Finally, UV-thermal denaturation experiments were used to compare the wild type and
mutant GQ stability for each RNA. Samples of 10 µM RNA in 10 mM cacodylic acid, pH 6.5,
were thermally denatured in the presence of 1 mM and 2.5 mM KCl for the GQ2 mutant and
Shank1a GQ mutant, respectively, monitoring the absorbance changes at 295 nm, the wavelength
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Figure 5. Full UV-thermal denaturation spectra of figure 3E and 3F. A) Shank1a GQ mutant.
Shank1a GQ mutant was denatured in the presence of 2.5 mM KCl and 10 mM cacodylic acid,
pH 6.5 B) PSD-95 GQ2 mutant. PSD-95 GQ2 mutant was denatured in the presence of 1 mM
KCl and 10 mM cacodylic acid, pH 6.5.

most sensitive to GQ dissociation (Mergny et al. 1998). The KCl concentrations used were chosen
so the resulting data could be compared to previously published data of the wild type sequences.
The UV thermal denaturation profile for Shank1a GQ mutant at 2.5 mM KCl contained a
hypochromic transition which was fit with equation 1 (Materials and Methods) to determine a Tm
of ~63°C (Figure 5A and Figure 3E), compared to the wild type ~73°C (Zhang et al. 2014).
Additionally, there is a hyperchromic transition starting at ~75°C, absent from the UV thermal
denaturation profile of the wild type Shank1a (Zhang et al., 2014) that we attribute to the melting
of the alternate bimolecular structure stabilized by Watson-Crick base pairs. The UV thermal
denaturation profile of the PSD-95 GQ2 mutant at 1 mM KCl contained a hypochromic transition
that was fit with equation 1 (Materials and Methods) to determine a Tm of ~80°C (Figure 5B and
Figure 3F), slightly higher than that for the wild type Q2 quadruplex at ~74°C (Stefanovic et al.
2014). These data show that the mutant PSD-95 and Shank1a mutant RNAs retain the ability to
form parallel GQ structures. The Shank1a mutant RNA can also form an alternative bimolecular
structure stabilized by Watson-Crick base pairs.
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Figure 6. FUS binds mutant PSD-95 GQ2 and Shank1 GQ mutant structures. 20% Native
PAGE, 88 volts, 4°C for 4 hours followed by UV-shadowing. A) PSD-95 GQ2 mutant (lane 1)
in the presence of increasing FUS RGG3 concentrations (lanes 2-4). B) Shank1a GQ mutant
(lane 1) in the presence of increasing FUS RGG3 concentrations (lanes 2-4).

Having shown that the mutant RNAs retain GQ structures, native PAGE was used to test
the FUS RGG3 binding to the RNA mutant GQ structures in the absence of the GGUG recognition
motif (Figure 6A and 6B). The band corresponding to the free mutant PSD-95 GQ2 (Figure 6A,
lane 1), diminishes significantly upon addition of FUS RGG3 peptide at a 1:1 ratio (lane 2) and
disappears completely at a 1:2 ratio (lane 3), comparable with the wild type PSD-95 GQ (Figure
2A). The Shank1a GQ mutant adopted two conformations as evidenced by the presence of two
bands in figure 6B, lane 1. Both bands stained for the GQ specific dye N-methyl mesoporphyrin
IX (Nicoludis et al. 2012) (data not shown), indicating that both conformations contain GQ
structures. The lower band was attributed to the unimolecular GQ structure, whereas the upper
band could correspond to the predicted bimolecular structure containing Watson-Crick base pairs
capped by GQ structures at the end. The lower band corresponding to the unimolecular Shank1a
GQ disappears when increasing FUS RGG3 concentrations are added due to the overall positive
charge of the Shank1a GQ mutant – FUS complex (Figure 6B, lanes 2-4). The bimolecular
Shank1a GQ mutant (upper band) is also bound by the FUS RGG3 peptide, but in this case the
complex appears as a super-shifted band due to the overall negative charge of complex that now
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contains two RNA strands. Taken together, these results indicate that the GQ structure per se is
sufficient for recognition and binding by the FUS RGG3 domain.

Chapter 1.3 FUS has a nanomolar dissociation constant for neuronal RNA GQ structures.
To measure the dissociation constant of the complex formed by FUS with the wild-type PSD-95
GQ2 and Shank1a GQ, we employed steady-state fluorescence spectroscopy. Single nucleotide 2aminopurine (2AP) substitutions were made in the Shank1a GQ and PSD-95 GQ2 at positions 18
and 4, respectively (circled in Figure 1B). 2AP is a highly fluorescent analogue of adenine whose
stead-state fluorescence is sensitive to its microenvironment (Bharill et al. 2008, Seranno-Andrés
et al. 2006), allowing for monitoring of protein-nucleic acid interactions. Increments of FUS
RGG3 or full-length FUS were titrated into annealed samples of 150 or 200 nM PSD-95 GQ2 or
Shank1a GQ in 10 mM cacodylic acid, pH 6.5, and 150 mM KCl, while monitoring the changes
in steady-state fluorescence of the 2AP reporter (Figure 7A and 7C). A five-fold excess of an
unrelated peptide derived from the hepatitis C virus core protein (Ivanyi-Nagy 2006) was used to
screen non-specific interactions between FUS RGG3 and RNA.
These experiments were performed in triplicate for each RNA and the dissociation constant, Kd,
was determined for each experiment by fitting the binding curve with equation 4 (Materials and
Methods). Reported Kd represent an average of the three Kd values and the reported error is the
standard deviation. The Kd for the Shank1a GQ - FUS RGG3 peptide complex was determined to
be 271 ± 21 nM and the Kd for the PSD-95 GQ2 - FUS RGG3 peptide complex was 92 ± 9 nM
(Figure 7A and 7C).
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Figure 7. FUS binding Shank1a GQ and PSD-95 GQ2 fluorescence. FUS RGG3 was titrated in
to 150 nM or 200 nM A) Shank1a GQ and C) PSD-95 GQ2 in the presence of five-fold excess
HCV peptide. Full-length FUS was titrated in to 150 nM or 200 nM B) Shank1a GQ and D)
PSD-95 GQ2 in the presence of five-fold excess BSA. Steady-state fluorescence data was fit
with equation 4 (material and methods). Kd values represent the average of the three fits for each
experiment. Error represents the standard deviation of the fit.
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Figure 8. Shank1a GQ and PSD-95 GQ2 control fluoresce. BSA was titrated in to 200 nM A)
PSD-95 GQ2 or B) Shank1a GQ.3

Next, we measured the dissociation constant of the complex formed by the full length FUS with
these GQs. Wild–type FUS was recombinantly expressed using a plasmid encoding for the GSTFUS fusion protein (a kind gift from Dr. Daryl Bosco, Department of Neurology, University of
Massachusetts) and purified as described in Sama et al., 20017. Similar fluorescence spectroscopy
experiments were performed with the full-length FUS in the presence of five-fold excess BSA,
and binding curves were fit to equation 4 (Materials and Methods). The Kd for the Shank1a GQ –
FUS complex had a value of 88 ± 27 nM whereas that for the PSD-95 GQ2 – FUS complex had a
value of 28 ±10 nM (Figure 7B and 7D). In both cases, the Kd for the full-length FUS binding was
lower than that of the isolated FUS RGG3. Control experiments in which BSA was titrated, showed
as expected, no change of the steady state fluorescence of the 2AP reporters (Figure 8), indicating
that the changes in fluorescence observed in figure 7 result from FUS-GQ RNA binding.
It is possible that FUS RGG3 is not solely responsible for binding to the RNA GQ
structures. The other RGG domains of FUS may contribute to binding, or alternatively, in the
context of the entire protein, the RGG3 domain might be better oriented allowing it to bind with
greater affinity to the GQ structures. Further studies are required to further probe the source of
increased affinity of the full-length protein for these neuronal GQ forming mRNAs. In this study,
we demonstrated for the first time that FUS recognizes the GQ structures formed by two neuronal
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mRNAs, PSD-95 and Shank1, which encode for proteins important for synaptic plasticity and
maintenance. Moreover, we proved that the GQ structure is sufficient for recognition, as the
GGUG sequence was not required for binding. Our results support these findings, expanding the
class of GQ RNA structures recognized by FUS and provide for the first time, quantitative
information about FUS’s affinity for GQ RNA structures. The dissociation constants we measured
for the complexes formed by FUS with PSD-95 GQ2 and Shank1a GQ are in the nanomolar range:
28 ± 10 nM and 92 ± 9 nM, respectively. Previous studies have shown that FMRP binds neuronal
GQ forming mRNAs with nanomolar affinity to regulate their translation (Blice-Baum and
Mihailescu 2014, Evans et al. 2012, Stefanovic et al. 2015, Zhang et al. 2014). Since FUS binds
PSD-95 GQ2 and Shank1a GQ with similar affinity as FMRP, it is likely that FUS plays an
important functional role in the synaptic plasticity and maintenance of the neuronal cells, though
further investigation is required to observe a direct correlation between the protein-nucleic acid
interactions and health of the neuronal cell.
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Chapter 2: (G4C2)4 is Targeted by RGG Containing RNA-binding Proteins
Chapter 2.1 Introduction. Large hexanucleotide expansions of GGGGCC (G4C2) repeats in the
5' region of intron 1 in the C9ORF72 gene are the most common genetic cause for amyotrophic
lateral sclerosis (ALS) and frontotemporal dementia (FTD) (DeJesus-Hernandez et al. 2011,
Renton et al. 2011). These disorders belong to a spectrum of neurodegenerative disorder with
overlapping clinical symptoms, pathology, and mechanisms. Symptoms of ALS are fatal and
characterized by motor neuron loss in the brain and spinal cord (Haverkamp et al. 1995). FTD is
the second most common form of dementia (Van Langenhove et al. 2012) and results in
degeneration of the frontal and anterior lobes of the brain, leading to progressive abnormalities in
personality, behavior, and language (McKhann et al. 2001, Neary et al. 1998). ALS and FTD
symptoms are observed in individuals displaying 250-1600 repeats, while unaffected individuals
contain 2-19 repeats (Gomez-Tortosa et al. 2013). When the mRNA transcript is expressed from
the expanded region, the transcript aggregates into RNA foci (DeJesus-Hernandez et al. 2011). The
(G4C2) repeat expansion has been identified in at least 8% of sporadic ALS/FTD cases and over
40% of familial cases (DeJesus-Hernandez et al. 2011, Majounie et al. 2012, Renton et al. 2011).
One hypothesis for the repeat expansion pathogenesis is the the (G4C2) and/or antisense
(G2C4) RNA transcripts undergo repeat-associated non-ATG translation, producing predicted GlyAla, Gly-Pro, Gly-Arg, Pro-Ala, and Pro-Arg dipeptides that may aggregate and lead to a toxic
gain of function (Ash et al. 2013, La Spada and Taylor 2012). While dipeptide repeat inclusions
were minimal in lower motor neurons, they were abundant in the frontal cortex and cerebellum in
(G4C2) expansion cases, however, no pathological correlation could be identified for specific
dipeptide repeat protein pathology (Mackenzie et al. 2015).
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A second hypothesis that is continuously gaining supporting evidence, is that the
transcribed (G4C2) and/or antisense (G2C4) RNAs sequester RNA-binding proteins, inhibiting their
normal cellular function. (G4C2) RNA foci have been observed in both the nucleus and cytoplasm
of the motor cortex and spinal cord of ALS/FTD patients (DeJesus-Hernandez et al. 2011) and in
C9ORF72 ALS induced pluripotent stem cells differentiated into neurons (Donnelley et al. 2013),
giving ample opportunity for interactions with RNA-binding proteins.
The guanine rich expansion of the RNA transcript prompted our research group, as well as
others to investigate the potential for GQ formation (Fratta et al. 2012, Reddy et al. 2013). Three
GGGGCC-repeats and adjacent GGGGC nucleotides were predicted to form a guanine (G)
quadruplex structure and were then characterized using 1H NMR and circular dichroism
spectroscopy, revealing (G4C2)3GGGGC as a parallel intramolecular GQ structure (Fratta et al.
2012), while studies in our lab indicate that (G4C2)4 exists in equilibrium between a GQ and an
extended hairpin.
GQ structures have been bound and recognized by proteins that are involved in a wide
variety of processes including alternative splicing, RNA transport, translation regulation, RNA
degradation, and repeat expansion diseases (Collie et al. 2011, Cooper et al. 2009, Ji et al. 2011).
It was shown that the GQ forming RNA foci are more abundant in C9ORF72 ALS patient
fibroblasts and astrocytes than individuals without the expansion and that the RNA foci co-localize
with hnRNP H/G protein (Conlon et al. 2016). Additionally, the (G4C2) expansion repeats localize
at the neurites and are associated with deleterious effects on neuronal branching, while alteration
of dFMR1 levels, the Drosophila homolog of the fragile X mental retardation protein (FMRP), a
transport granule component, impacts neuritic defects induced by the antisense (G2C4) expansion
in vivo in Drosophila (Schweizer Burguete et al. 2016). FMRP, a GQ RNA-binding protein, was
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shown to colocalize with (G4C2)48 in neuritic granules in rat spinal cord neurons (Schweizer
Burguete et al. 2016).
FMRP is primarily expressed in neurons and testes, contains a nuclear export and nuclear
localization signal used to shuttle between the nucleus and cytoplasm, and two types of RNAbinding motifs: two K-homology (KH) domains and one arginine-glycine-glycine rich region
(Kim et al. 2009, Sittler et al. 1996, Tamanini et al. 1999). The RGG domain of FMRP specifically
binds to the GQ structure (Darnell et al. 2001, Jin and Warren 2003, Blice-Baum and Mihailescu
2014, Evans et al. 2012, Stefanovic et al. 2014, Stefanovic et al. 2015, Zhang et al. 2014). FMRP
uses its RGG domain to bind the RNA GQ secondary structure of multiple RNAs and may also
target the (G4C2)4 repeat. An additional RNA-binding protein containing RGG domains is human
FUS, which was shown to specifically bind the repeat expansion in a cell pulldown (Mori et al.
2013) and was sequestered in cells expressing 31 of the repeats (Rossi et al. 2015). The C-terminal
RGG motif has even been shown to bind to a GQ forming DNA and RNA telomeric repeat
(Takahama et al. 2013) as well as neuronal mRNAs Shank1 and PSD-95 (as described previously).
In C9ORF72 repeat-expansion patient cells and tissues, it was observed that splicing error rate was
associated with disease severity (Cooper-Knock et al. 2015), suggesting that RNA-binding protein
sequestration may be a pathogenic mechanism.
Since FMRP and FUS were both shown to co-localize with the repeat expansion and
contain RGG binding domains, known to target GQ structures, we therefore hypothesized that
FMRP and FUS bind the (G4C2)4 GQ through their RGG domains. In ALS/FTD cases caused by
the repeat expansion, these interactions may lead to sequestration of FMRP and FUS in RNA
aggregates along with other RNA-binding proteins. This may remove FMRP/FUS from potentially
vital cellular functions including RNA trafficking and splicing processes, leading to RNA

18

misprocessing and/or toxic gain of function. Other GQ binding proteins may be affected by a
similar mechanism. It is therefore important to elucidate the potential of FMRP and FUS to bind
the (G4C2)4 GQ to further understand the effects of this repeat expansion in ALS and FTD
pathogenesis.

Chapter 2.2 (G4C2)4 forms a GQ structure. In vitro T7 transcription was used to generate the
(G4C2)4 RNA from a DNA template and then used in 1D 1H NMR experiments in the presence of
increasing KCl concentrations, while monitoring the imino proton resonance region. The GQ

Figure 9: (G4C2)4 characterization. A) 1D 1H NMR spectra of (G4C2)4 at increasing KCl
concentrations. All spectra with exception of the top spectrum were obtained for non-denatured
RNA samples. B) 1D 1H NMR spectra of (G4C2)4 at 150 mM KCl over time. All spectra were
obtained for non-denatured RNA samples. C) Conformational changes within (G4C2)4 under
increasing KCl concentration (0, 5, 10, 25, 50, 100, 150 mM). RNA concentration was kept
constant at 10 μM. D) CD spectra shows the GQ formation in the (G4C2)4 RNA by titrating
increasing concentrations of KCl.
secondary structure has signature resonances centered around 10–12 ppm that correspond to the
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imino protons involved in Hoogsteen hydrogen bonding that stabilize the structure, whereas the
imino-proton resonances for canonical Watson-Crick base pairs (G-C and A-U) have a chemical
shift between 12-14.5 ppm. Imino resonances between 10-12 ppm indicative of a GQ were
observed as a weak and broad signal even in the absence of salt, due to the high concentration of
guanine residues able to engage in Hoogsteen hydrogen bonding (Figure 9A). However, strong
resonances at 12-14.5 ppm indicative of Watson-Crick base pairing were observed, indicating
(G4C2)4 exists in equilibrium between a GQ and a more stable hairpin conformation (Figure 10).
When 10-150 mM KCl was titrated into the sample, the resonances for the GQ structure increased
as the structure was stabilized by increasing K+ concentration, however, the resonances
corresponding to the hairpin structure were still predominant.

Figure 10. Predicted hairpin
structure of (G4C2)4.

To assess which secondary structure is favored when starting from the denatured (G4C2)4
sequence in the presence of salt, samples containing 150 mM KCl were boiled for 5 minutes at 95
°C to denature the sequence, followed by cooling to room temperature on the bench top. WatsonCrick imino proton resonances between 12-14.5 ppm were significantly diminished in the 1H NMR
spectra and significant enhancement of the GQ imino proton resonances between 10-12 ppm were
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observed, indicating higher stability of the GQ structure (Figure 9A top spectra). The broad
character of the imino resonances in the 10-12 ppm region may be due to multiple GQ structures
coexisting in equilibrium. We next studied the equilibrium between the GQ and hairpin structure
in the presence of 150 mM KCl at 37 °C. After in vitro transcription was employed to provide new
(G4C2)4 RNA, the sample was suspended in 10 mM cacodylic acid, pH 6.5 and 150 mM KCl. This
sample was then incubated at 37 °C and 1H NMR spectra were acquired as a function of time
(Figure 9B). During days 0-5, the imino resonances indicative of Watson-Crick base pairs were
observed but displayed reduced intensity over time, while GQ resonances increased in intensity.
After two weeks, resonances in the 12-14.5 ppm region were drastically reduced, while the GQ
was further stabilized, indicating the GQ is the favored and more thermodynamically stable
conformation in vitro. These results support previous work showing the repeat expansion forms a
GQ structure (Fratta et al. 2012, Haeusler et al. 2014, Reddy et al. 2013). However, it has not been
shown that the GQ is stabilized as the hairpin destabilized as a function of time. Though the
equilibrium of the GQ and hairpin structure may also may also be affected by cellular conditions,
such as RNA-binding proteins that may stabilize one structure over the other, our results indicate
that the GQ structure is the favored conformation by the (G4C2)4 repeats. The GQ structure may
therefore be the predominant structure in ALS/FTD patients.
The KCl salt dependence of the GQ structure was also investigated by native PAGE. In the
absence of salt, a single conformation was observed and was attributed to the hairpin structure
(Figure 9C, lane 1). Upon increasing salt concentration, a second higher molecular weight band
was observed concomitant with the disappearance of the lower band (Figure 9C, lanes 2-7). At
150 mM KCl the higher molecular

21

Figure 11. UV-thermal denaturation profile of (G4C2)4 A) UV thermal denaturation profile of
(G4C2)4 RNA in 10 mM cacodylic acid and 150 mM KCl shows the dissociation of hairpin from
45 to 60 °C and the GQ dissociation from 85 to 95 °C. B) UV thermal denaturation profile of
(G4C2)4 after 11 weeks of equilibration at 37 °C. The transition for the hairpin is no longer
observed and the hypochromic transition of the GQ dissociation is no longer fully visible due to
stabilization.

weight band, which was attributed to the GQ structure, was predominant (Figure 9C, lane 7). The
anticipated K+ stabilization of the GQ structure was observed and favored intracellular conditions
of ~150 mM KCl, supported by 1H NMR experiments. To then investigate if the the fold of the
GQ structure is parallel or antiparallel, CD spectroscopy was used. Even in the absence of K+, the
CD spectra had a positive band at ~ 265 nm and a negative band at 240 nm (Figure 9D), the
characteristic CD spectra of a parallel GQ (Williamson 1994). As KCl was titrated into the (G4C2)4
RNA, both the positive and negative band intensities increased as the GQ was stabilized. Upon
annealing the RNA in 150 mM KCl at room temperature, the GQ was promoted further, consistent
with 1H NMR results and previously published CD spectra (Fratta et al. 2012, Haeusler et al. 2014,
Reddy et al. 2013).
UV thermal-denaturation experiments were used to determine the thermodynamic stability
of the (G4C2)4 GQ (Figure 11). The temperature of a 10 μM RNA sample in 150 mM KCl and 10
mM cacodylic acid, pH 6.5, was increased from 25 °C to 95 °C at a rate of 0.20 °C/min. while
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absorbance at 295 nm was recorded. Overall, three transitions were observed in the spectra (Figure
11A). The first hypochromic transition between 33 to 43° C is attributed to stacking interactions
between multiple GQ structures, a hyperchromic transition between 45 and 60 °C corresponding
to the unwinding of the hairpin, and the second hypochromic transition between 73 and 95 °C,
which is attributed to the more stable GQ structure. After allowing the sample to reach equilibrium
over time at 37 °C, the (G4C2)4 RNA was anticipated to contain a single transition corresponding
to the stabilized GQ, with the hairpin structure becoming a minimally occupied state. Upon melting
the RNA, two transitions were observed (Figure 11B), one around 30 °C which was attributed to
stacking of the quadruplex structures, and a main hypochromic transition from the unwinding of
the GQ, which started around 70 °C. The full transition was not observed due formation of a single
GQ conformation, which has high thermodynamic stability. This data implies that the GQ structure
is the more thermodynamically stable and favored structure for (G4C2)4 and that upon reaching
equilibrium, the GQ has a high thermodynamic stability.
After characterizing (G4C2)4, we used in vitro T7 RNA polymerase driven transcription to
generate a longer sequence containing 8 (G4C2) repeats, (G4C2)8. 1D 1H NMR spectra were
acquired in the presence of increasing KCl concentrations, while monitoring the imino proton
resonance region (Figure 12A). In the absence of KCl, resonances between centered around 10.1
and 10.5 ppm were observed. These are likely amino proton resonances that are not indicative of
G quadruplex formation. Additionally, sharp resonances between 12-14.5 ppm are observed,
corresponding to Watson-Crick base pairing. As KCl was increased from 10-150 mM KCl, the
two broad resonances between 10-11 ppm collapsed into a single resonance with slightly enhanced
intensity.
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Figure 12. (G4C2)8 1H NMR. A) 1H 1D NMR of the (G4C2)8 RNA repeats in the presence of
increasing KCl concentration. All spectra with exception of the top spectrum were obtained for
non-denatured RNA samples. B) 1D 1H NMR spectra of (G4C2)8 at 150 mM KCl over time. All
spectra were obtained for non-denatured RNA samples

Figure 13. Predicted hairpin structures of the
repeat expansion. A) Predicted hairpin structure of
(G4C2)8. B) Predicted hairpin structure of (G4C2)4.
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Upon annealing the sample in the presence of 150 mM KCl, a very broad resonance between 1012 ppm attributed to the GQ structure was stabilized concomitant with reduction of Watson-Crick
resonances to very low intensity. The (G4C2)8 construct therefore exists primarily as a hairpin
structure until annealed, where the denatured sample favors GQ formation in the presence of KCl.
The NMR spectra for (G4C2)8 is notably different than that of (G4C2)4, where the G quadruplex
does not appear to form until annealed. The Watson-Crick resonances are also altered and are
attributed to subtle differences in the predicted hairpin structures where the shorter repeat contains
a GG bulge, whereas the longer repeats contain single G bulges (Figure 13).
When (G4C2)4 was equilibrated over time in the presence of 150 mM at 37 °C, the hairpin
became destabilized concomitant with the stabilization of the GQ structure (Fig 9). To determine
if (G4C2)8 would have a similar equilibrium, a new sample was transcribed and resuspended in 150
mM KCl and 10 mM cacodylic acid, pH 6.5. An initial 1H NMR spectrum was obtained at 37 °C
followed by subsequent scans as a function of time (Figure 12B). Two broad imino proton
resonances attributed to the GQ formation were observed, centered around 11 ppm, while WatsonCrick resonances were observed between 12-14.5 ppm. Subsequent spectra were acquired after 1,
5, and 14 days of equilibration. As anticipated, the GQ resonances were stabilized, concomitant
with the reduced intensity in Watson-Crick resonances. However, the sample reached equilibrium
after 14 days of incubation and no further change was observed in the spectra. With increased
repeat length, the hairpin and GQ structures are both stabilized due to an increase in the interactions
stabilizing the structures. Furthermore, the Watson-Crick resonances show a different signature
than the original sample. Time dependent spectra were taken at 37 °C rather than 25 °C. This may
have provided enough energy to begin unwinding the hairpin, allowing for stabilization of the GQ.
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The tails of the GQ would then be able to participate in Watson-Crick base pairing, allowing for
the stabilization of both structures, as observed in the NMR spectra.
The thermodynamic stability of the (G4C2)8 construct was then probed by UV-thermal
denaturation. The sample temperature was raised from 25 °C to 95 °C at a rate of 0.20 °C/minute
while monitoring the absorbance at 295 nm (Figure 14A). A broad hyperchromic transition was
observed from 35 °C to 85 °C for the unwinding of the hairpin conformation. The beginning of
the hypochromic transition of the GQ dissociation did not start until 85 °C and was therefore not
fully observed before 95 °C was reached. This data suggests that the hairpin and GQ both have a
high thermodynamic stability, which may explain why the GQ structure was no longer favored at
equilibrium compared to the shorter (G4C2)4 RNA construct, which had a hairpin with significantly
lower thermodynamic stability.
We then used CD spectroscopy to determine the fold of the GQ structure (Figure 14B). As
with the (G4C2)4 construct, the CD spectra of the (G4C2)8 RNA GQ also contained a positive band
at ~265 nm and a negative band at ~240 nm, indicative of a parallel GQ fold. CD spectra was also
acquired as function of temperature (Figure 14C). The observed bands showed only a minor
reduction in intensity by 95 °C, supporting the UV-thermal denaturation data which suggest a high
thermodynamic stability of the GQ.
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Figure 14. UV-thermal denaturation profile and CD-spectroscopy of (G4C2)8. A) UV-thermal
denaturation of the (G4C2)8 sample in the presence of 150 mM KCl and 10 mM cacodylic acid,
pH 6.5. The hairpin dissociation is observed as a slow, hyperchromic transition between 35 and
85 °C. The GQ dissociation begins around 85 °C but is still stable at 95 °C. B) CD spectra of
(G4C2)8 with a positive band at 265 nm and a negative band at 240 nm, indicative of a parallel
GQ structure. C) CD spectra of (G4C2)8 as a function of temperature. Even at 95 °C, only a minor
reduction in intensity of the GQ bands is observed.
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Chapter 2.3 Interactions of the (G4C2)4 RNA with the RGG box of FMRP and FUS. To further
test our hypothesis that FMRP and FUS bind the (G4C2)4 GQ through their RGG domains, we next
analyzed the interactions between (G4C2)4 and FMRP RGG peptide (Table 2) using native PAGE
where (G4C2)4 was boiled in the presence of 150 mM KCl. Lane one contains free RNA shown as
two bands, the lower band corresponding to the hairpin formation and the darker higher molecular
weight band corresponding to the GQ structure (Figure 15A). This sample was still in equilibrium
between the two conformations, hairpin and GQ, with the hairpin acting as an internal control.
Two-fold FMRP RGG peptide is added in lane 2 and the disappearance of the GQ band is observed
due to overall positive charge of the GQ in complex with the positively charged peptide sequence.
At a four-fold peptide ratio, lane 3, the GQ band intensity is further reduced. We then used the
complementary C-rich hairpin sequence as an additional control (Figure 15B). As a two-fold and
four-fold peptide ratio were added to the free RNA, no shift was observed, indicating that the
FMRP RGG domain specifically targets the (G4C2)4 GQ structure.
We then used steady-state fluorescence spectroscopy to determine the dissociation constant
(Kd) of the interactions to probe the affinity of the RGG domain for the GQ. A (G4C2)4 RNA
construct was designed with a fluorescent cytosine analog, pyrrollo-C, at position 11. The
fluorescence emission of pyrrolo-C is sensitive to its microenvironment, which will be altered by
protein binding and can be monitored at 451 nm (Tinsley and Walter 2006). After the free RNA
was equilibrated and steady-state fluorescence emission at 451 nm was recorded, binding curves
were obtained by titrating increasing concentrations of the FMRP RGG domain peptide or fulllength protein into a fixed RNA concentration while monitoring changes in fluorescence emission
(Figure 15C and 15D). As the protein concentration was increased, a reduction in fluorescence
intensity was observed.
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FMRP RGG

RRGDGRRRGGGGRGQGGRGRGGGFKGNDDHSR

FUS RGG3

APKPDGPGGGPGGSHMGGNYGDDRRGGRGGYDRGGYRGRGG
DRGGFRGGRGGGDRGGFGPGKMDSRGEHRQDRRERPY

Table 2. Amino acid sequence of the FMRP and FUS RGG domains.

Figure 15. Binding of FMRP and (G4C2)4. A) EMSA of the 10 μM (G4C2)4 RNA in the presence
of 150 mM KCl binding with the FMRP RGG box at different RNA:RGG ratios. B) EMSA of
the 10 μM (G2C4)4 RNA in the presence of 150 mM KCl is not bound by FMRP RGG box. C)
Steady-state fluorescence spectroscopy of FMRP RGG peptide binding (G4C2)4 RNA. Upon
fitting, a Kd = 153 ± 58 nM was obtained. D) Steady-state fluorescence spectroscopy of FMRP
isoform 1 binding (G4C2)4. After curve fitting, a Kd = 198 ± 63 nM was obtained.
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Figure 16. Binding of FUS and (G4C2)4. A) EMSA of the (G4C2)4 RNA in the presence of 150
mM KCl binding the FUS RGG3 at increasing RNA:RGG ratios. B) Steady-state fluorescence
spectroscopy of FUS RGG3 binding (G4C2)4 RNA. Upon curve fitting, A Kd = 451 ± 57 nM
was obtained. C) Steady-state fluorescence spectroscopy of full-length FUS binding (G4C2)4
RNA. Upon curve fitting, A Kd = 206 ± 34 nM was obtained. D) Steady-state fluorescence
spectroscopy of R495X mutant FUS binding the (G4C2)4 RNA. Upon curve fitting a Kd of 42 ±
15 nm was obtained.

These experiments were performed in the presence of five-fold excess of unrelated HCV
peptide or BSA to screen non-specific interactions. All experiments were performed in triplicate
and the Kd for each experiment was determined by fitting the binding curves to Equation 4
(Materials and Methods). The resulting Kd for the RGG-(G4C2)4 complex was 153 ± 58 nM, while
the full-length FMRP-(G4C2)4 complex Kd was 198 ± 63 nM. The Kd of the complexes were
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comparable, indicating tight and specific binding between the FMRP RGG domain and the (G4C2)4
GQ structure.
Having shown the FMRP RGG domain binds the repeat, native gel electrophoresis was
used to determine if FUS RGG3 domain can also target the (G4C2)4 RNA (Figure 16A). This
experiment was done using the (G4C2)4 sample that equilibrated at 37 °C as a function of time.
Lane 1, therefore, appears as a single conformation attributed to the GQ structure. Upon addition
of FUS RGG3, lane 2, the free RNA band intensity was reduced and by a three-fold peptide ratio,
lane 4, the band had entirely shifted, indicating that FUS RGG3 is able to bind (G4C2)4. To obtain
quantitative data on binding affinity that can be compared to the FMRP binding results, we
repeated the steady-state fluorescence experiments using the FUS RGG3 domain peptide and fulllength protein (Figure 16B and 16C). Upon fitting the resulting data to Equation 4 (Materials and
Methods), the Kd was determined to be 451 ± 57 nM for the RGG3 domain while the full-length
protein Kd was 206 ± 34 nM. The Kd for the FUS RGG3 peptide was notably different from that
of the FMRP RGG domain peptide with the FMRP RGG domain binding with greater affinity,
while full-length FUS bound with a similar affinity to full-length FMRP. Of interest, the steadystate fluorescence emission of pyrrolo-C increased upon full-length FUS binding. This suggests a
different mechanism of binding between the full-length and isolated RGG3 domain. To further
investigate this, a FUS mutant containing an early termination signal leading to the loss of the
RGG3 domain, R495X, was used in steady-state fluorescence spectroscopy experiments (Figure
16D). Unexpectedly, the fluorescence emission again was reduced upon binding and the resulting
Kd was 42 ± 15 nm, a ten-fold increase in binding affinity from the RGG3 domain peptide. Though
the RGG3 domain of FUS is capable of binding to the (G4C2)4 GQ, it is not the primary proteinnucleic acid interaction in this complex. It is unclear if RGG1 and/or RGG2 domains are
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responsible for the binding interactions, further experiments will be required to probe these
interactions to determine the primary binding site.
In summary, the RGG domain of FMRP specifically binds to the (G4C2)4 GQ structure
using its RGG domain. Additionally, FUS was shown to specifically bind the repeat expansion in
a cell pulldown (Mori et al. 2013) and was sequestered in cells expressing 31 of the repeats (Rossi
et al. 2015), but quantitative data about this is not available. Here we present data, indicating that
FUS is able to directly bind the repeat expansion using it RGG3 C-terminal domain, however, the
full-length protein binds with higher affinity and surprisingly, the R495X mutant binds with a tenfold higher affinity than the RGG3 domain peptide. The C-terminal RGG3 domain has been shown
to bind GQ forming telomeric DNA and RNA, while RGG1 and RGG2 domains were not
(Takahama et al. 2013). This study is adds to our previous data showing direct interaction of FUS
with GQ forming neuronal mRNAs and is the first study to show the potential interactions of
RGG1 and/or RGG2 domains with a GQ structure. Overall, this data supports the current
hypothesis that suggests a potential pathogenic mechanism by which the repeat expansion could
sequester RGG domain containing RNA-binding proteins via the RNA GQ structure and adds
FMRP and FUS to the list of protein targets.
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Chapter 3: Fragile X Mental Retardation Protein Recognizes a GQ Structure in the Survival
Motor Neuron Domain Containing 1 mRNA 5’-UTR
Chapter 3.1 Introduction. A variety of protein activity regulation strategies occur posttranscriptionally, mainly at the level of mRNA translation. The 5’- and 3’- untranslated regions
(5’- and 3’-UTRs) of mRNA templates contain cis-acting structural moieties and this regulation
may involve both sequence and secondary structure(s) of these non-protein coding regions
(Huppert et al. 2008, Pesole, et al. 2001). Among these structures involved in translation regulation
is the mRNA GQ. In addition to 5’-UTR activities such as translation inhibition, the GQ structure
has been implicated in other location-based processes, such as regulation of alternative splicing
when in the coding region as well as translation regulation via the microRNA pathway and/or
increased polyadenylation efficiency when in the 3’UTR (Beaudoin et al. 2013, Blice-Baum et al.
2014, Didiot et al. 2008, Fratta et al. 2012, Gomez et al. 2004, Hai et al. 2008, Huppert et al. 2008,
Jin, Alisch, and Warren 2004 , Jin, Zarnescu, et al. 2004, Stefanovic et al. 2015, Zhang et al. 2014).
It is known that the genetic information governing translation is primarily localized in the
5’- and 3’-UTRs of mRNA (Neubauer et al. 1998). Based on the G3+N1–7G3+N1–7G3+N1–7G3+ RNA
sequence (where N is any nucleotide), bioinformatics analyses have predicted that 2334 and 3530
GQs occur in the 5’- and 3’-UTRs, respectively, of human mRNA transcripts from known proteincoding genes (Huppert et al. 2008). The prevalence of GQs in the 5’-UTR suggests a role in the
regulation of translation considering the advantageous control of the process at or near its point of
initiation. Moreover, these mechanisms might have different layers of complexity, as the
regulatory function of the GQ structure in translation could also be mediated by its interactions
with specific RNA binding proteins.
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Chapter 3.2 Fragile X Mental Retardation Protein and SMNDC1 mRNA. Fragile X mental
retardation protein (FMRP), is an RNA binding protein implicated in translation, whose loss of
expression leads to a constitutive increase in the synthesis of certain dendritic proteins and results
in the most prevalent inherited intellectual disability in humans: fragile X syndrome (FXS)
(Crawford et al. 2001, O’Donnell et al. 2002). FMRP is primarily expressed in neurons and the
testes, and it contains an RGG domain, two K-homology domains, a nuclear localization signal
(NLS), and a nuclear export signal (NES). There are different FMRP isoforms produced by
alternative splicing and the three longest FMRP isoforms involve alterations near its RGG box
domain (Ashley et al. 1993, Verkerk et al. 1993). The longest FMRP isoform 1 (ISO1) has 632
amino acids, followed by the second- (ISO2) and third-longest (ISO3) isoforms truncated 13 and
25 residues, respectively, upstream of the RGG box. FMRP normally inhibits the translation of
target mRNAs, with relief of inhibition triggered by synaptic input enabling local protein synthesis
(Nalavadi et al. 2012, Narayanan et al. 2007). Additionally, FMRP uses its NLS and NES to shuttle
between the nucleus and cytoplasm, acting to transport mRNAs throughout the cell (Kim et al.
2009, Sittler et al. 1996, Tamanini et al. 1999). In general, the RGG box domain is characterized
as having two or three RGG repeats, with five to nine residues separating the repeats, and has been
identified in 44 human proteins (Corley
et al. 2008, Kiledjian et al. 1992). FMRP has been shown to use its RGG box domain to bind
mRNA targets that form GQ structures (Blice-Baum et al. 2014, Bole et al. 2008, Darnell et al.
2001, Evans et al. 2012, Menon et al. 2007, Menon et al. 2008, Penagarikano et al. 2007, Zanotti
et al. 2006, Zhang et al. 2014). However, with the exception of the microtubule associated protein
1B (MAP1B) mRNA 5’-UTR (Menon et al. 2008) and the human achaete-scute homologue-1
(hASH1) mRNA 5’-UTR, (Fahling et al. 2009) characterization of the FMRP RGG box binding
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GQ structures has focused on coding region and 3’-UTR locations (Blice-Baum et al. 2014, Bole
et al. 2008, Evans et al. 2012, Menon et al. 2007, Zhang et al. 2014).
We are expanding these studies to analyze neuronal mRNAs that have the potential to form
GQs in their 5’-UTR and be regulated by FMRP. Among these is the survival motor neuron domain
containing 1 mRNA (SMNDC1, also known as survival of motor neuron-related splicing factor
30, SPF30), which has been predicted by bioinformatics to form a GQ structure located in its 5’UTR (Huppert et al. 2008, Kikin et al. 2006). Furthermore, from the 12 predicted mature SMNDC1
mRNA transcripts, four contain this predicted GQ forming sequence at relatively similar locations
near the beginning of the 5’-UTR (Kim et al. 2005). These locations near the 5’ end of the mature
transcript 5’-UTR suggest a role in translation inhibition. SMNDC1 mRNA has been shown to be
constitutively transcribed in skeletal muscle as well as in fetal and adult brain and spinal cord
(Talbot et al. 1998). Furthermore, SMNDC1 mRNA has been identified as a potential FMRP target
via PAR-CLIP analysis (Ascano et al. 2012). The corresponding SMNDC1 protein has been
implicated in pre-mRNA splicing and is critical for spliceosome assembly in the nucleus (Meister
et al. 2001, Neubaeur et al. 1998, Rappsilber et al. 2001, Talbot et al. 1998, Tripsianes et al. 2011).
A noteworthy activity of SMNDC1 involves its Tudor domain, a domain that has been shown to
bind methylated arginines in arginine and glycine rich regions such as the glycine-arginine-rich
(GAR) domain and, as found in FMRP, the RGG box domain (Stetler et al. 2006, Thandapani et
al. 2013, Tripsianes et al. 2011). Given that FMRP has been shown to bind to the hASH1 mRNA
5’-UTR GQ, resulting in an increased translation efficiency (Fahling et al. 2009), additional
sequences with 5’-UTR GQ structures may have a similar mechanism of regulation. A typical
outcome of FXS is that proteins are overexpressed if their corresponding mRNAs are a target of
FMRP. Depletion of FMRP associated with FXS could affect the levels of SMNDC1 protein via
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dysregulation of SMNDC1 mRNA translation. SMNDC1 overexpression has been implicated in
apoptosis, thus if SMNDC1 mRNA is a target of FMRP then this outcome could supplement the
current knowledge of FXS etiology (Talbot et al. 1998). SMNDC1 is a partial paralog of the
survival motor neuron protein (SMN), with both proteins having seemingly similar functions
(Meister et al. 2001, Talbot et al. 1998). Low levels of SMN caused by deletions or mutations in
the smn1 gene leads to the spinal muscular atrophy neuromuscular disease (Fallini et al. 2012,
Lefebvre et al. 1995). Being overshadowed by SMN in spinal muscular atrophy, the biological
function of SMNDC1 has not been fully elucidated.
In this study, we have shown by biophysical and biochemical methods that a guanine-rich
25 nucleotide stretch within the SMNDC1 mRNA 5’-UTR folds into a stable GQ structure which
is recognized with high affinity and specificity by the full-length recombinant FMRP ISO1, as well
as by endogenous FMRP in mouse brain lysates. Altogether, the results of this study show for the
first time that FMRP interacts with the SMNDC1 mRNA 5’-UTR, via recognition of a GQ
structure by its RGG box domain. While it is postulated that FMRP interacts with the microRNA
(miRNA) pathway to regulate the translation of specific mRNAs via direct interactions with 3’UTR sequences, the mechanism(s) by which it regulates translation via interactions within the
mRNA’s 5’-UTR remains largely unknown. It is expected that the results of this study will spur
further research into elucidating such mechanism(s).
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Chapter 3.3 Structural and thermodynamic characterization of the SMNDC1 mRNA GQ.
The GQ predicting software QGRS Mapper (Kikin et al. 2006) predicted the formation of a GQ
structure within the 5’-UTR of the SMNDC1 mRNA (BC039110.1) (Huppert et al. 2008). To
experimentally confirm the existence of this GQ structure, a 25 nucleotide fragment encompassing
the 18 nucleotide sequence predicted to fold into the GQ structure (Figure 17) was generated by
in vitro transcription from a synthetic DNA template.
We first used 1D 1H NMR spectroscopy to analyze GQ structure formation within
SMNDC1 RNA in the presence of increasing KCl concentrations, monitoring the imino proton
resonance region. Even in the absence of KCl, imino proton resonances were present in the 10-12
ppm region, which correspond to guanine imino protons involved in G quartet formation through
Hoogsteen base pairs, indicating that the 25 nucleotide SMNDC1 mRNA fragment forms a GQ
structure (Figure 18A). While K+ ions are required for DNA GQ formation, RNA sequences are
able to fold into GQs even in their absence (Joachimi et al. 2009). A few broad resonances are
present in the 12-14.5 ppm region, where imino protons involved in Watson-Crick base pairs
resonate, indicating the formation of a minor alternate structure. The increase in resonance
intensities in the signature 10-12 ppm range while increasing K+ concentrations indicates the GQ
structure stabilization by K+ ions. The broadness of these resonances suggests the existence of
alternative structure conformers.
We synthesized a mutant sequence having strategic G-to-C substitutions designed to
abolish the GQ structure (Figure 18B). 1D 1H NMR spectroscopy experiments were performed to
probe the structure of the mutant construct. Previously observed resonances in the signature 10-12
ppm GQ imino proton region were replaced by resonances in the 12-14.5
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Figure 17. SMNDC1 sequence. A) Sequence of the mutant 25 nt segment from the SMNDC1
mRNA 5’-UTR. Locations of G tracts predicted to be involved in the GQ structure are underlined.
B) Proposed parallel, intramolecular GQ structure formed by the 25 nt fragment from the 5’ UTR
of SMNDC1 mRNA. The naturally occurring cytidine at position 12 substituted by the PC
fluorescent analog is circled.

Figure 18. 1H NMR of SMNDC1. A) Characteristic Watson-Crick base-pairing resonances of the
1D 1H NMR spectra of 230 µM mutant SMNDC1 mRNA in 10 mM cacodylic acid, pH 6.5, 40°C,
in the presence of increasing KCl concentrations. B) Characteristic Watson-Crick base-pairing
resonances of the 1D 1H NMR spectra of 230 µM mutant SMNDC1 mRNA in 10 mM cacodylic
acid, pH 6.5, 40°C, in the presence of increasing KCl concentrations. Absence of characteristic GQ
structure imino proton resonances indicates that the mutant version of SMNDC1 RNA does not
form the GQ structure.
38

ppm region corresponding to Watson-Crick base pairs, thus demonstrating that the GQ formed in
the SMNDC1 wild-type sequence is abolished in the mutant construct and that a hairpin structure
is dominant in the mutant construct. Additional biophysical methods such as CD spectroscopy and
UV-thermal denaturation experiments were used by collaborating students to ascertain structural
and thermodynamic properties of the wild-type 25 nucleotide fragment from the SMNDC1 mRNA
5’-UTR (McAninch et al. 2017). Our results demonstrate that this mRNA fragment adopts a
dominant GQ structure that is intramolecular, has a parallel strand orientation, comprised of three
G quartet planes, coordinates ~2.6 K+ ions, and has high stability at the physiologic temperature
(data not shown).

Chapter 3.4 FMRP interactions with the SMNDC1 mRNA GQ. FMRP is an RNA binding
protein primarily found in neurons, where SMDNC1 expression has been demonstrated (Talbot et
al. 1998). Though the regulatory mechanism is not well understood, FMRP is proposed to bind
specific neuronal mRNAs in the nucleus, then use its NLS and NES to shuttle them throughout the
cell, regulating translation in response to synaptic input (Bechara et al. 2009, Darnell et al. 2001,
O’Donnell et al. 2002). The activity of FMRP is critical for humans since its absence leads to FXS,
the most common inheritable intellectual disability (Crawford et al. 2001, O’Donnell et al. 2002).
The RGG box domain within FMRP has been shown to bind GQ forming mRNAs with high
affinity and specificity, including those within the 5’-UTR of other neuronal targets and, like
SMNDC1 mRNA, those devoid of a stem structure (Blice-Baum et al. 2014, Bole et al. 2008,
Darnell et al. 2001, Evans et al. 2012, Laggerbauer et al. 2001, Menon et al. 2007, Menon et al.
2008, Siomi et al. 1993, Zhang et al. 2014). The GQ itself has also been shown to regulate mRNA
translation (Arora et al. 2008, Bugaut et al. 2012, Gomez et al. 2010, Halder et al. 2009, Huppert
et al. 2008, Kumari et al. 2007, Kumari et al. 2008, Pesole et al. 2001, Shahid et al. 2010, Wieland
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et al. 2007) and it has been proposed that FMRP binding the GQ structure enables an additional
level of translation regulation (Brown et al. 2001, Menon et al. 2008, Sung et al. 2003, Westmark
et al. 2007, Zalfa et al. 2003, Zalfa et al. 2005).
Since SMNDC1 mRNA has been identified as a potential FMRP target via PAR-CLIP
analysis (Ascano et al. 2012) we investigated if the 5’-UTR SMNDC1 mRNA GQ is bound by
FMRP. We used a 32mer peptide consisting of the FMRP RGG box domain (Table 2) that has
been previously shown to bind GQ RNA targets with comparable affinity and specificity to fulllength FMRP ISO1 as well as ISO2 and ISO3 (Blice-Baum et al. 2014, Bole et al. 2008, Evans et
al. 2012 Menon et al. 2007, Menon et al. 2008, Zanotti et al. 2006, Zhang et al. 2014). Native
EMSA PAGE performed at constant RNA and KCl concentrations, with 1:0, 1:1, 1:2, and 1:3
FMRP RGG box peptide:SMNDC1 mRNA ratios, demonstrated the formation of a higher
molecular weight complex via the emergence of an upper band in the presence of the FMRP RGG
box peptide, with the concomitant decrease in intensity of the lower band that corresponds to the
free RNA (Figure 19A, compare lanes 1 vs. 2-4).
To demonstrate that the GQ structure formed in the SMNDC1 mRNA segment is
specifically targeted by FMRP, native EMSA PAGE was performed using the mutant RNA
construct, and as FMRP RGG peptide concentration was increased a single band corresponding to
the free RNA remained (Figure 19B), demonstrating that elimination of the GQ structure in the
mutant construct ablates binding. Altogether, these findings further support the conclusion that the
RGG box domain of FMRP specifically binds to the GQ structure within the 5’-UTR of SMNDC1
mRNA.
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Figure 19. FMRP binding SMNDC1. 20% native PAGE of A) 10 μM SMNDC1 mRNA and B)
SMNDC1 mutant RNA in the presence of 5 mM KCl, with increasing FMRP RGG peptide.
Gels were visualized by UV shadowing at 254 nm. C) FMRP RGG box peptide and D) fulllength FMRP ISO1 individually titrated into 150 nM SMNDC1_12PC RNA in the presence of
150 mM KCl, 10 mM cacodylic acid, pH 6.5, at 25°C with 5:1 BSA protein to screen nonspecific interactions.
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Figure 20. SMNDC1 fluorescence control. Fluorescence spectroscopy curve of SMNDC1
12PC RNA while titrating binding negative control BSA in the presence of 150 mM KCl, 10
mM cacodylic acid, pH 6.5, at 25°C. Results indicate specific binding of SMNDC1 RNA by
FMRP ISO1 and the RGG box peptide. The lack of PC reporter quenching upon titrating BSA
indicates the quenching from separately titrating FMRP ISO1 and FMRP RGG box peptide
are not due to non-specific protein aggregation and are instead a result of specific binding.

Next, we employed steady-state fluorescence spectroscopy to obtain quantitative
information regarding the interactions of the FMRP RGG box peptide and of the full-length FMRP
ISO1 protein with the 5’-UTR SMNDC1 mRNA GQ. We designed SMNDC1_12PC RNA, which
was formed by the labeling of the 25 nt GQ forming SMNDC1 mRNA fragment with the
fluorescent cytosine analog PC in place of the cytidine at position 12. The fluorescence emission
of PC is sensitive to changes in its local microenvironment, including those induced by protein
binding (Tinsley et al. 2006). Binding curves were obtained by titrating increasing concentrations
of either the RGG box peptide (Figure 19C) or FMRP ISO1 (Figure 19D) into a fixed RNA
concentration. To ensure that the observed PC quenching is not due to non-specific protein
aggregation, similar control experiments were performed by titrating BSA and, as expected, the
steady state fluorescence of the PC reporter did not change (Figure 20). All experiments were
performed in triplicate and the Kd for either the RGG peptide or FMRP ISO1 were determined by
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fitting the binding curves with Equation 4 (Materials and Methods). Though the full length FMRP
ISO1 binds with greater affinity (Kd = 211 ± 42 nM) than the RGG box peptide (Kd = 365 ± 67
nM), both values are consistent with other nM affinities demonstrated by either the FMRP RGG
box peptide or various FMRP isoforms binding to other GQ forming RNAs (Blice-Baum et al.
2014, Bole et al. 2008, Evans et al. 2012 Menon et al. 2007, Menon et al. 2008, Zanotti et al. 2006,
Zhang et al. 2014). Additionally, though the affinities between FMRP ISO1 and the RGG box
peptide are statistically different, they correspond to comparable free energies of binding of –9.1
± 0.2 kcal/mol and –8.8 ± 0.2 kcal/mol respectively. Furthermore, these free energy values are
consistent with the recently characterized affinity of FMRP for two GQ structures from the 3’UTR of Shank1 as well as other mRNAs (Blice-Baum et al 2014, Evans et al. 2012, Zhang et al.
2014).
Lastly, experiments performed in Dr. Bassell’s lab at Emory University using a biotinRNA pull-down assay, demonstrated binding of endogenous brain FMRP to the SMNDC1 mRNA
GQ. Biotin-labeled SMNDC1 RNA probes were incubated with E17 mouse brain lysates followed
by precipitation via NeutrAdivin agarose. Subsequent Western blot analysis demonstrated that the
SMNDC1 RNA probe is bound by endogenous FMRP but not the negative control, SMN (Figure
21), thus indicating SMNDC1 mRNA is specific for FMRP and devoid of non-specific interactions
with other proteins.
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Figure 21. SMNDC1 pulldown in E17 mouse brain lysates. Binding of 5’ biotinylated
SMNDC1 mRNA by FMRP after incubation with E17 mouse brain lysates. RNA probes were
precipitated and potential co-purified FMRP and SMN proteins were assessed by immunoblot.
Precipitated SMNDC1 mRNA was simultaneously exposed to immunoblot by FMRP and SMN
with all other samples. However, the gel contained mRNA targets unrelated to this study, thus
the SMNDC1 samples are shown in a separate window.

GQ structures have been identified in the 5’-UTR of a number of genes and while a large
majority have been shown to inhibit translation there are examples in which they stimulate
translation (Agarwala et al. 2013, Agarwala et al. 2014, Bonnal et al. 2003, Morris et al. 2010).
Our results that show for the first time that SMNDC1 mRNA forms a GQ structure in its 5’-UTR,
thus suggesting a possible translation regulatory function for this structure. FMRP is proposed to
be a translation repressor of specific mRNA targets at distal sites and, until responding to synaptic
input, local protein translation will be inhibited. The exact mechanisms by which FMRP exerts its
translation regulator function are not known. However, it has been shown that, for mRNA targets
that are bound by FMRP in their 3’-UTR, this might be mediated by interactions with the miRNA
pathway (Edbauer et al. 2010, Muddashetty et al. 2011, Stefanovic et al. 2015). Though it has been
shown that translation increased in the absence of FMRP for two mRNAs that each have at least
one potential GQ structure in their 5’-UTR (Castets et al. 2005, Lu et al. 2004), only one study
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analyzed the FMRP RGG box directly binding the GQ structure (Menon et al. 2008) and our
findings that FMRP interacts with a GQ in the SMNDC1 5’-UTR expands this short list.
Another intriguing hypothesis is that FMRP could play an indirect role in splicing, by
modulating the levels of the SMNDC1 protein, a critical component of the spliceosome. The
SMNDC1 protein has been found in Cajal bodies, implicated in the splicing of mRNA in cells with
elevated metabolic activity such as neurons and proliferating cells (Little et al. 2008, Rappsilber
et al. 2010). The SMNDC1 protein also contains the basic Tudor domain, which has binding
activity for methylated arginines in arginine and glycine rich regions such as GAR and RGG box
domains. When in Cajal bodies, the SMNDC1 protein has been shown to use its Tudor domainprotein binding activity during spliceosome assembly and formation of mature small nuclear
riboproteins (Cote et al. 2005, Little et al. 2008, Liu et al. 2012, Meister et al. 2001, Pek et al.
2012, Rappsilber et al. 2001, Talbot et al. 1998, Tripsianes et al. 2011). This Tudor domain activity
is noteworthy given that FMRP uses its RGG box domain to bind GQ mRNAs as well as has been
shown to undergo arginine methylation within its RGG box (Stetler et al. 2006, Thandapani et al.
2013, Tripsianes et al. 2011). Though SMNDC1 protein has not yet been investigated for direct
interactions with FMRP, its SMN paralog, also containing the Tudor domain, has been shown to
interact with FMRP in vitro and in cellulo (Piazzon et al. 2008). Furthermore, the Tudor domain
containing 3 (TDRD3) protein has been shown to interact with the methylated RGG box of FMRP
(Xu et al. 2013) as well as its paralogs FXR1 and FXR2 (Linder et al. 2008, Stoll et al. 2013, Xu
et al. 2013). This TDRD3-FMRP complex is associated with a mRNA pool actively undergoing
translation (Stoll et al. 2013), and has been proposed to promote translation of these mRNAs (Xu
et al. 2013). One could envision a potential regulatory loop in which the SMNDC1 protein could
use its Tudor domain to bind methylated arginines within the FMRP RGG box domain, affecting
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the ability of this domain to interact with the GQ structure located in its 5’-UTR, which in turn
will affect the translation of the SMNDC1 mRNA, and hence the levels of the SMNDC1 protein.
Further research is needed to explore such a potential regulatory mechanism.
Overall, our results provide further evidence that GQ structures with consistent structural
and thermodynamic properties exist in neuronal mRNAs, which was implied by other indirect
methods (Subramanian et al. 2011). We show for the first time that a GQ structure forms in the 5’UTR of SMNDC1 mRNA and that this structure is sufficient for recognition by FMRP. This study
provides the foundation of potential relationships between levels of proteins, translation activity,
and splicing activity that are mediated by GQ mRNAs, FMRP and its RGG box domain, and
SMNDC1 and its Tudor domain. These findings merit further investigation of these relationships,
further support the role of FMRP in FXS, and suggest that the molecular mechanism of impairment
involves the loss of regulation for neuronal mRNA localization and/or translation.
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Chapter 4: hnRNP Q1 Binds a GQ Structure in the 5’-UTR of GAP43
Chapter 4.1 hnRNP Q1 and GAP43 mRNA. Heterogenous ribonucleoprotein Q, isoform 1
(hnRNP Q1 [Mourelatos et al. 2001]) is a protein highly expressed in the brain (Mizutani et al.
2001, Rossoll et al. 2002, Xing et al. 2012). It contains two RNA-binding domains, three RNArecognition motifs, and an RGG domain (Mourelatos et al. 2001). hnRNP Q1 is primarily localized
to the nucleus, suggesting that functions in mRNA translation, localization, and decay regulation
may be its major role (Mourelatos et al. 2001). Supporting this, hnRNP Q1 has been shown to
participate in several mRNA processing events, including splicing, editing, transport, translation,
and decay (Wigington et al. 2014). Specifically, hnRNP Q1 represses RhoA mRNA translation
and regulates Cdc42 mRNA localization (Chen et al. 2012, Xing et al. 2012). Given the high
expression of hnRNP Q1 in the brain, many mRNAs involved in neuronal development and
function may be targeted by the protein and regulated post-transcriptionally.
GAP43 is a neuron-specific protein involved in regulation of neuronal development,
plasticity, and regeneration (Denny 2006). GAP43 appears to function in axonal growth as it is
enriched in growth cones after polarity is established and accumulates along nascent axons in
cultured hippocampal neurons (Goslin et al. 1990). GAP43 overexpression results in increased
neuronal growth (Aigner et al. 1995, Donnelly et al. 2011,2013, Leu et al. 2010), the importance
of which is underscored in GAP43 deficient mice, which demonstrate impaired neuronal
development and axon guidance (Donovan et al. 2002, Shen et al. 2002, McIlvain et al. 2003,
Strittmatter et al. 1995). GAP43 function is not isolated to nascent axons. During axon
regeneration, GAP43 expression is increased (Erzurumlu et al. 1989, Van der Zee et al. 1989)
which further promotes axon sprouting and regeneration after injury (Campbell et al. 1991,
Schreyer and Skene 1991, Andersen and Schreyer 1999, Grasselli et al. 2011, Allegra Mascaro et
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al. 2013). GAP43 also functions in learning and memory formation (Rekart et al. 2005, Holahan
and Routtenberg 2008) and altered GAP43 expression is linked to brain disease (de la Monte et al.
1995, Bogdanovic et al. 2000, Tian et al. 2007, Zaccaria et al. 2010).
Multiple mechanisms of regulation of been studied for GAP43 (Chiaramello et al. 1996,
Diolaiti et al. 2007, Tedeschi et al. 2009, Weber and Skene 1997). Including a mechanism of
mRNA localization to dorsal root ganglia of axons by the mRNA-binding protein IMP1/ZBP1
(Donnelly et al. 2011). GAP43 mRNA translation is likely to be regulated as well but has not been
investigated. The goal of this research project is to demonstrate a mechanism by which hnRNP Q1
regulates GAP43 translation via interactions between hnRNP Q1 and a GQ structure in the 5’UTR
of GAP43.

Chapter 4.2 Characterization of the GAP43 mRNA GQ. This project determined that hnRNP
Q1 knockdown resulted in increased nascent axon length, total neurite length, and neurite number
in mouse embryonic cortical neurons and enhanced Neuro2a cell process extension (Williams et
al. 2016). GAP43 knockdown was then able to recover these phenotypes. Within the 5’-UTR of
the GAP43 mRNA, we identified a GQ structure that is directly targeted by hnRNP Q1 for
repression of the mRNA, a function which may be critical for neuronal development. My part of
this project was to assist in biochemical and biophysical characterization of the GQ structure and
to demonstrate specific binding of GAP43 by hnRNP Q1.
Our lab determined that the GQ structure within the 5’-UTR of GAP43 adopts a parallel
intramolecular fold (Figure 22), which upon disruption of G tracts removes GQ folding (Figure
23). To determine the thermodynamic stability and intermolecular or intramolecular nature of the
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Figure 22. Proposed parallel, intramolecular GQ structure formed by the 20-nucleotide
fragment from the GAP43 mRNA.

Figure 23. 1H NMR of GAP43 mutant. 1D 1H NMR spectroscopy with the mutant GAP43
revealed that imino proton resonances are not present in the 10-12 ppm region demonstrating
that mutation of guanine residues that are involved in GQ formation prevents the structure from
forming. Imino proton resonances are present in the 12.6-13.4 ppm region, which correspond to
Watson-Crick G-C base pairs.
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Figure 24. GAP43 UV-thermal denaturation experiments. A) GAP43 mRNA GQ was denatured
in the presence of 10 mM cacodylic acid, pH 6.5 and 5 mM KCl. Shown as an insert is a
representative fit of the hypochromic transition using equation 1 (Materials and Methods),
assuming a two state model. B) Plot of Tm at varying RNA concentration. Using equation 1
(Materials and Methods), we are able to show that the fold is not RNA concentration dependent
and therefore adopts a intramolecular fold.

GQ, UV-thermal denaturation experiments were performed by monitoring the change in
absorbance at 295 nm (Mergny et al. 1998), while increasing the temperature from 25 °C to 95 °C
(Figure 24A) The main hypochromic transition with a Tm of 78 °C is present in the UV thermal
denaturation profile at 295 nm, corresponding to GQ dissociation. An additional minor transition
is observed above 90 °C at high RNA concentrations, attributed to the formation of alternate
intermolecular conformations promoted by high RNA concentration. To determine if the GQ
adopts an intramolecular or intermolecular nature, thermal denaturation experiments were
performed at a fixed KCl concentration while the RNA concentration was varied. The resulting Tm
were not dependent on RNA concentration (Figure 24B) indicating that the GAP43 GQ adopts an
intramolecular fold (Equations 1 and 2). After establishing the main transition as a intramolecular
GQ, we fit the transition using equation 3 (Materials and Methods), which assumes a two-state
model, to determine the
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Figure 25. hnRNP Q1 binding GAP43. A) 20% native PAGE of 500 nM GAP43 mRNA in the
presence of 10 mM KCl, with increasing hnRNP Q1 RGG peptide. Gels were visualized by SYBR
gold staining. B) hnRNP Q1 RGG peptide titrated into 150 nM GAP43 RNA in the presence of 150
mM KCl, 10 mM cacodylic acid, pH 6.5, at 25°C with 5:1 HCV peptide to screen non-specific
interactions. The Kd resulting from the fit was 131 ± 14 nM.

thermodynamic parameters of GQ formation in the presence of 5 mM KCl (Figure 24A insert).
The enthalpy of formation of a single G quartet plane has been reported to range between -18 and
-25 kcal/mol (Hardin et al., 2000). Thus, the value obtained for the enthalpy of GQ formation in
the 5′GQ RNA probe for the main transition (ΔH0 = -64.3 ± 0.1 kcal/mol) is consistent with the
presence of three G-quartet planes. Taken together, these results suggest that the 5′GQ folds into
a stable, parallel, intramolecular GQ structure containing three G-quartet planes (Figure 22).

Chapter 4.3 hnRNP Q1 interactions with the GAP43 mRNA GQ. Having characterized the
GAP43 GQ, we next used native PAGE to initially probe the interactions between hnRNP Q1 and
the GAP43 mRNA GQ structure (Figure 25A). The first lane contains free GAP43 mRNA and
appears as single band attributed to the GQ conformation. At a 1:1 ratio of GAP43:hnRNP Q1, the
intensity of the free mRNA is visibly reduced (lane 2) and at a 1:3 ratio (lane 4), the free RNA
band becomes further reduced and diffuse. At a 1:5 ratio, the band is almost entirely prevented
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from entering the gel due to hnRNP Q1 binding (lane 6). Steady-state fluorescence spectroscopy
was then used to determine the affinity of this binding interaction observed in native PAGE
experiments. A GAP43 RNA was designed with adenine at position four replaced with 2AP, a
highly fluorescent analogue of adenine sensitive to changes in microenvironment (Bharill et al.
2008, Serrano-Andres et al. 2006). The steady-state fluorescence emission of a 150 nM RNA
sample was allowed to equilibrate and recorded. This was then followed by 50 nM titrations of
hnRNP Q1 RGG peptide while monitoring the changes in 2AP steady state fluorescence emission
(Figure 25B). Resulting binding curves were fit using EQX (Material and Methods) to determine
a Kd of 131 ± 14 nM for the complex formed between GAP43 mRNA GQ and hnRNP Q1 RGG
peptide. Experiments were performed in triplicate with reported error representing the standard
deviation of the Kd from the three independent fits.
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Chapter 5: Conclusions and future work
The research presented in this dissertation displays novel RGG-domain containing RNA-binding
protein interactions with GQ structures in the context of neurodegenerative disease. The first
project presents a novel mode of binding between FUS and the GQ structures. Two neuronal
mRNAs involved in synaptic plasticity and maintenance, Shank1 (Boeckers et al. 2002) and PSD95 (Keith and El-Husseini 2008). Previously the only FUS-GQ interactions observed were for a
telomeric repeat containing GQ in DNA and RNA and were facilitated through the FUS RGG3
domain (Takahama et al. 2013). Our data indicates that the neuronal mRNA GQ structures of
Shank1 and PSD-95 are bound by FUS RGG3 with a Kd for each interaction in the nM range, with
the full-length protein binding with even higher affinity.
We then began investigating the interactions in the context of ALS/FTD causing FUS
mutations. Mutations near the RGG3 domain and NES of FUS lead to cytoplasmic aggregation
and cause familial ALS (Kwiatkowski et al. 2009, Vance et al. 2009). Mutant FUS aggregates in
the cytoplasm may trap GQ containing mRNAs, removing them from their normal cellular
function and contribute to ALS pathogenesis. We proceeded with one of these mutations, FUS
R495X, which results in the loss of the RGG3 domain. However, binding of the mutant R495X
with the Shank1a GQ and PSD-95 GQ2 mutant occurs with very low affinity. Overall these results
may indicate that the RGG3 domain is the primary domain used to facilitate GQ binding. The
R495X mutant may not contribute to ALS pathogenesis through GQ binding and sequestration,
however, it is anticipated that mutants such as R521G and R521C would still bind GQ structures
with high affinity and contribute to ALS pathogenesis through sequestration of the mRNA.
Future studies need to be performed to fully elucidate the mechanism by which FUS
recognizes GQ proteins, specifically, how the full-length protein increases affinity of the RGG3
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domain for GQ structures. Binding studies should be performed using two separate peptides for
the RGG1 domain and RGG2 domain, similar to what we demonstrate here with RGG3, to
determine if they alone can bind to GQ structures. Additionally, the affinity of FUS R521G and
R521C mutations for Shank1a GQ and PSD-95 GQ2 should be probed. It is anticipated that the
affinity will be similar to that of wild-type FUS and in the context of ALS, contribute to
pathogenesis through a GQ mRNA binding and sequestration mechanism.
We then investigated RGG domain-containing proteins targeting a GQ structure in the
context of the C9ORF72 repeat expansion. Our characterization of the (G4C2)4 RNA supports
previously published work showing repeat expansion formation of a parallel intramolecular GQ
structure (Fratta et al. 2012). We show for the first time that the repeat expansion is in equilibrium
between a hairpin and GQ structure where the GQ structure in the presence of 150 mM KCl is
favored in vitro and that given enough time, the equilibrium will shift almost entirely to GQ
structure formation. The repeat expansion in ALS/FTD cases, however, are much longer than what
we have investigated here. Thus, future work will investigate longer RNA expansions to determine
if a similar equilibrium, favoring GQ formation, is observed. Self-templating polymerase chain
reaction experiments can be used to produce DNA templates for use in in vitro T7 transcription
reactions to yield repeats with greater length for this purpose.
The leading hypothesis for pathogenicity of the repeat expansion is that the expanded RNA
repeats may form foci that sequester RNA-binding proteins, which will lose their normal cellular
function. We investigated the potential binding between the repeat expansion with FMRP and
FUS, two RGG domain containing RNA-binding proteins and measured nM binding affinity of
the FMRP RGG domain and full-length protein for (G4C2)4. As seen with Shank1a GQ and PSD95 GQ2, FUS RGG3 domain had a nM affinity for the repeat expansion with the full-length protein
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binding with even higher affinity. FUS R495X mutant bound with a tenfold higher affinity than
the RGG3 peptide, unlike the binding of Shank1a GQ and PSD-95 GQ2, which occurred with very
low affinity. This may indicate a different mode of binding where the RGG3 domain is not the
primary domain responsible for recognition of the repeat expansion.
Future studies will need to be performed similar to those discussed with Shank1a GQ and
PSD-95 GQ2, using specific sections of the protein to probe for relevant interactions with the
repeat expansion to elucidate the underlying mechanisms of the FUS RGG binding and
recognition. Additionally, longer repeats that more closely mimic pathogenic conditions need to
be tested for the affinity of RGG domain-containing proteins. While the RNA concentration would
be the same in steady-state fluorescence experiments, the increased repeat length will provide
additional binding sites for RGG domain recognition. Once bound and released, they may
immediately bind a nearby site, shifting equilibrium to the bound state. Increased repeat length
may also lead to the formation of binding pockets as the GQ structures stack and fold into an RNA
aggregate, this may sterically trap RGG domain-containing proteins leading to a lower Kd. This
research provides a strong foundation on which therapeutic agents for ALS/FTD can be designed
such as peptide nucleic acids (PNAs), which are DNA/RNA mimics with a modified backbone
containing a peptide-like N-(2-aminoethyl)-glycine. These PNAs could be designed to disrupt
these protein-nucleic acid interactions, preventing the sequestration of the RNA-binding proteins.
In the context of FXS, studies have focused on FMRP targeting GQ structures in the 3’UTR. Here we add to the small but growing list of 5’-UTR GQ structures that have been
characterized. We show that a parallel, intramolecular, GQ structure forms in the SMNDC1 5’UTR (McAninch et al. 2017) and that FMRP RGG domain and full-length protein display a nM
binding affinity for this GQ. A typical outcome of FXS is that proteins are overexpressed if their
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corresponding mRNAs are a target of FMRP. Given that SMNDC1 overexpression has been
implicated in apoptosis (Talbot et al. 1998), it is possible that in FXS cases, SMNDC1 will be
overexpressed due to loss of FMRP, leading to apoptosis and may be a contributing factor to FXS
symptoms. This study provides a link between translation activity, protein level, and splicing
activity mediated by GQ structures, the FMRP RGG domain, and SMNDC1. To investiagate the
link with FXS further, future work needs to be performed to determine if SMNDC1 becomes
overexpressed in FMRP knockout models and determine if this leads to apoptosis. These future
studies would further support the role of FMRP in FXS and the involvement of GQ structures in
the regulation of mRNA localization and/or translation.
Overall this research shows novel importance of RGG domain-containing RNA-binding
proteins and their regulation of mRNA localization, sequestration, and translation through
interactions with GQ structures. We show in several contexts, that regulation via these GQ
structures may be altered, contributing to pathogenic mechanisms leading to neurodegeneration.
Understanding these underlying mechanisms of recognition and the pathways they are involved in
allows for future development of therapeutics to slow or prevent neurodegenerative disease.
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Chapter 6: Materials and Methods
Chapter 6.1 RNA synthesis. Synthetic DNA templates (Trilink Biotechnologies, Inc.) were
synthesized by in vitro transcription using T7 RNA polymerase produced in-house (Milligan and
Uhlenbeck 1989). Oligonucleotides were purified by 20% 8 M urea denaturing polyacrylamide gel
electrophoresis (PAGE), electrophoretically eluted, and dialyzed against 10 mM cacodylic acid,
pH 6.5. Samples containing fluorescent analogues, 2-aminopurine or pyrrollo-C (Dharmacon,
Inc.), were used for steady-state fluorescence spectroscopy experiments.

Chapter 6.2 Peptide Synthesis. The FUS RGG peptide corresponding to the C-terminal RGG
region (RGG3) and FMRP peptide corresponding to its RGG region (Table 2) were chemically
synthesized by the Peptide Synthesis Unit at the University of Pittsburgh Center for Biotechnology
and Engineering. Full length HCV core protein is 191 amino acids long and contains three basic
domains (Cristofari et al. 2004, Ivanyi-Nagy et al. 2006). The first two domains, amino acids 2-23
and 38-74, were combined to form a 58 amino acid sequence peptide. This core peptide, named
2BD (Ivanyi-Nagy et al. 2006), was chemically synthesized by University of Pittsburgh Center for
Biotechnology and Engineering.

Chapter 6.3 FUS protein expression and purification. Plasmids encoding for full length and
mutant GST-fusion FUS, provided by Dr. Daryl Bosco at the University of Massachusetts Medical
School, were transfected into Rosetta II DE3 cells (Novagen). All media used in cell growth
consisted of Luria-Bertani (LB; Fisher Scientific) containing 200 µg/ml ampicillin (AMP; MP
Biomedical) and 15 µg/ml chloramphenicol (CHL; MP Biomedical). A single colony from streak
plates was added to 5 mL of media and placed in a shaker at 225 rpm for 6 hours at 37°C then
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added to 145 ml of media and incubated at 30°C overnight in a shaker at 225 rpm. Following
overnight incubation, two 1 L cultures were generated by adding 50 ml of the overnight culture to
each 4 L flask, and were incubated at 20° C for 6-8 hours. When the OD600 reached 0.8, 1 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG) and 5 mM ZnCl2 were added to each 1 L culture
for induction, and incubated for 22 hours in a shaker at room temperature. Cells were harvested by
centrifugation in 500 ml tubes, 4°C and stored overnight in freezer.
Cell cultures were thawed on ice and re-suspended in lysis buffer (30 ml of 50 mM Tris
pH 8.0, 1mM DTT, 0.1 mM EDTA, and protease inhibitor cocktail (Roche Diagnostics)) and 100
µg/ml RNase A. Samples were sonicated and then spun down at 13,000 rpm for 20 minutes at 4°C.
The supernatant was added to 0.25 g glutathione-resin suspended in 30 ml of 50 mM Tris pH 8.0.
This slurry was incubated on a rocker at 4°C for two hours and then poured into a column, washed
once with 10 ml of 50 mM Tris pH 8.0 and then eluted in five fractions by adding 15 ml of freshly
prepared elution buffer (10 mM L-Glutathione, 1 mM DTT, 500 mM Tris, pH 9.5) to the column.
The sample was dialyzed against 50 mM Tris pH 9.5 using a 30K centricon tube with a
nitrocellulose membrane.

Chapter 6.4 Polyacrylamide gel electrophoresis. RNA samples were annealed by heating at
95°C in the presence of KCl and slowly cooled for 20 min to 25°C. For binding experiments, the
peptide was then added in varying ratios and allowed to equilibrate at 25°C for 20 min. Samples
were loaded onto 20% acrylamide:bis-acrylamide gels and run at 88 V for approximately 4 hours,
at 4°C. Gels were visualized by UV-shadowing at 254 nm (Hendry and Hannan 1996) or by
staining with N-methylmesoporphyrin IX and imaged using an AlphaImager (AlphaInnotech).
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Chapter 6.5 1H NMR Spectroscopy. The 1D 1H NMR spectra were acquired using a 500 MHz
Bruker AVANCE spectrometer to analyze an RNA sample in 90% H2O and 10% D2O in 10 mM
cacodylic acid, pH 6.5 solution. GQ formation was observed by titrating KCl from a 2 M stock,
allowing for equilibration, and monitoring the imino proton resonance region at 10-12 ppm. Water
suppression was accomplished using the Watergate pulse sequence (Piotto et al. 1992).

Chapter 6.6 Circular Dichroism (CD) Spectroscopy. The CD spectra were collected using a
Jasco J-810 spectropolarimeter at 25°C, with scans from 180 nm to 400 nm, using a 200 μL quartz
cuvette (Starna Cells) with a 1 mm path-length. Each set of conditions was scanned three times
with a 1 sec response time and a 2 nm bandwidth. All spectra were corrected for solvent
contributions and dilutions. For the K+-dependent GQ formation analysis, 10 μM RNA samples
were annealed in the absence of KCl and spectra recorded. KCl was then titrated and allowed to
equilibrate followed by spectra acquisition.

Chapter 6.7 UV spectroscopy thermal denaturation.

The UV spectroscopy thermal

denaturation curves were obtained using a Varian Cary 3E spectrophotometer equipped with a
Peltier temperature control cell. Experiments were performed in a 200 μL quartz cuvette (Starna
Cells) with a 10 mm path length, up to a final volume of 200 μL, and changes in absorbance at 295
nm were monitored. Sample and reference cells were covered with 200 μL mineral oil to prevent
evaporation. The RNA samples were heated during analysis from 25°C to 95°C at a rate of
0.2°C/min, recording absorbance every 1°C, monitoring the absorbance changes at 295 nm,
wavelength sensitive to GQ dissociation.(39)
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To determine if an intramolecular or intermolecular GQ structure is formed the melting
temperature (Tm) was determined at RNA concentrations were varied in the presence of KCl. The
Tm is indicated by the midpoint of the hypochromic transition during the thermal denaturation, and
the Tm for an intermolecular species containing n number of strands is dependent on the total RNA
concentration (cT), the gas constant (R), and the Van’t Hoff thermodynamic parameters (ΔH°vH and
ΔS°vH) (Equation 1).
1
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However, the Tm of an intramolecular GQ for which n = 1 is independent of cT, thus,

equation 1 reduces to Equation 2:
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The hypochromic transition of the UV thermal spectrum was fit to determine the

thermodynamic parameters of folding, assuming an independent two-state model, where AU and
AF represent the absorbance of the unfolded and folded GQ, respectively, and R is the universal
gas constant (Equation 3).
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Chapter 6.8 Steady-state fluorescence spectroscopy. Steady-state fluorescence spectroscopy
experiments were performed on a Horiba Jobin Yvon Fluoromax-3 with accompanying software
fitted with a 150 W ozone-free xenon arclamp. Experiments were performed in a 150 µL sample
volume, 3-mm path-length quartz cuvette (Starna cells). The excitation wavelength for the 2-AP
containing samples was set to 310 nm with bandpass excitation and emission of the
monochromators set to 5 nm, and the emission recorded between 330-450 nm. For pyrrollo-C
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experiments, steady-state fluorescence was monitored at 445 nm with excitation at 350 nm. All
binding experiments were performed at 23°C. Increasing concentrations of the respective peptide
or full-length protein were titrated against a fixed RNA concentration of 150 or 200 nM in 10 mM
cacodylic acid, pH 6.5, in the presence of KCl. Experiments were performed in the presence of
five-fold excess BSA or HCV specific peptide to reduce non-specific binding. Emission values
were corrected for free peptide or full-length protein and data normalized to free RNA fluorescence
intensity. Experiments were performed in triplicate, intensity was normalized for each experiment
and plotted as a function of the peptide or protein concentration and fit to Equation 4:
𝐼𝐼

𝐹𝐹 = 1 + �𝐼𝐼𝐵𝐵 − 1� ×
𝐹𝐹
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2×[𝑅𝑅𝑅𝑅𝑅𝑅]𝑡𝑡

where IF and IB represent steady-state fluorescence intensities of free and bound RNA, respectively.
[RNA]t is the total fixed RNA concentration and [P]t is the total protein concentration. The proteinRNA complex dissociation constant, Kd, was determined for each experiment by fitting binding
curves with Equation 4. Reported Kd represents an average of the three Kd values and standard
deviation from the average fit reported as error.
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Appendix
Abstract
The liver specific microRNA-122 (miR-122) has been shown to facilitate replication and/or
translation of the Hepatitis C virus (HCV). Although the exact role played by miR-122 in this
process is not fully understood, it has been shown that one of the functions of miR-122 is to
stabilize the HCV RNA genome upon binding. It has also been shown that miR-122 is a valid
antiviral target, as locked nucleic acids (LNAs) developed against miR-122 abolished HCV
replication. However, miR-122 has numerous other functions in the hepatic cell, which will also
be affected by LNAs. In this study, we adopted a different approach by designing peptide nucleic
acids (PNAs) against the highly conserved miR-122 binding sites within the HCV genome, and
tested their antiviral properties. Our results indicate that one such PNA binds to the 5’-untranslated
region (5’UTR) of the HCV genome. Moreover, this PNA has the ability to invade the HCV 5’UTR
- miR-122 complex, preventing miR-122 from exerting its beneficial function upon HCV
replication and/or translation.

Introduction
Hepatitis C Virus (HCV) is a positive stranded RNA virus that belongs to the Flaviviridae family
and the Hepacivirus genus (Lavanchy 2009). Capable of establishing lifelong persistence in those
persons infected (Lemon et al. 2007), the effects of the virus pose a great risk. Approximately 4
million Americans are persistently infected with HCV, and an estimated 12,000 deaths annually
are attributed to the effects of the virus, namely cirrhosis and hepatocellular carcinoma (Davis et
al. 2010). Worldwide, 130 million people are infected with estimates of 350,000 deaths annually
related to HCV infection (Perz et al. 2006).
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Figure 26. miR-122 binding S1 or S2 of the 5’-UTR. Base pairing of seed sequence as well as
supplemental base pairing is highlighted.

In the presence of the HCV viral genome, the liver specific microRNA-122 (miR-122) will
bind two sites, named S1 and S2, containing complementary sequences located within the HCV
RNA 5’ untranslated region (5’UTR) (Jopling et al. 2008). The highly structured 5’UTR of the
HCV viral genome conserved across all genotypes (Beales et al 2001, Friebe et al. 2005) and
contains the CACUCC sequence that is complementary to miR-122 seed sequence (Figure 26).
Although the mechanism by which miR-122 increases viral production is not fully understood,
binding of miR-122 to the 5’UTR of HCV mRNA amplifies viral transcript stability and
production of infectious virions (Shimakami et al. 2012 A).
The current HCV therapy involving pegylated alpha interferon and ribavirin has limited
efficiency in eliminating the infection and is relatively toxic (Shimakami et al. 2009). Thus, there
is a clear need for improved therapeutic options. One approach was to use locked nucleic acids
(LNAs) that specifically targeted miR-122 (Lavanchy 2009). LNAs contain a methylene carbon
that bridges the 2’ and 4’ position of the ribose ring (Figure 26), pre-organizing the backbone and
increasing the stability of the oligomer with each LNA substitution (Nulf and Corey 2004). LNAs
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target miR-122, which is involved in many metabolic processes in the normal functioning liver
and will therefore affect these as well. A more direct approach is to use peptide nucleic acids
(PNAs) that will target the HCV RNA. PNAs are DNA/RNA mimics with a modified backbone
containing a peptide-like N-(2-aminoethyl)-glycine (Figure 26). PNAs are protected from both
proteases and nucleases and are capable of invading DNA-DNA and RNA-RNA duplexes due to
thermodynamic favorability as the backbone is neutral and will have no electrostatic repulsion
between the PNA and its target (Nielsen 2001). Traditional PNAs presented the problem of low
water solubility, poor cell uptake, and aggregation. The addition of diethylene glycol (MiniPEG)
has been shown to significantly improve the water solubility of PNAs and retain their ability to
invade B-form DNA (Bahal et al. 2012). The newest PNA generation developed in the Ly lab at
Carnegie Mellon University are synthesized with a guanidino substitution at the α or γ carbon, a
modification which increases cell permeability.
The miR-122 binding sites within the HCV genome are highly conserved across all
genotypes (Li et al. 2011), making them attractive antiviral targets. Thus, in this study we designed
a PNA against the S2 site (PNA-S2) and performed in vitro biochemical and biophysical
experiments to evaluate its potential to bind to its target site on the viral RNA and prevent the
function of miR-122.

Results and Discussion
miR-122 and PNA-S2 bind the 5'UTR. The first 46 nucleotides of the HCV genome 5’UTR,
which contain both the miR-122 S1 and S2 binding sites, were used as our model-system for the
HCV 5’UTR, named 5’UTR+. It has been shown, indirectly, that miR-122 will bind to S1 and S2
sites within the 5’UTR of the HCV genome (Jopling et al. 2008), and to confirm this, native PAGE
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Figure 27. Binding of miR-122 and HCV 5’-UTR. 15% Native PAGE stained with ethidium
bromide, showing miR-122 binding to HCV 5’-UTR+ in increasing ratios. miR-122 binds 1:1

was employed. As miR-122 concentration was increased, the disappearance of the 5’UTR+ band
concomitant with the appearance of the shifted 5’UTR+ - miR-122 complex band was observed
(Figure 27). Complete disappearance of the control band is first observed in lane 5, indicating that
binding occurs in a 1:1 ratio. Regulation of gene expression by miR-122 has been shown to require
loading of miR-122 into RNA induced silencing complex (RISC) (Shimakami et al. 2012 A). An
expected 1:2 RNA:miR-122 ratio may not occur as the samples do not contain RISC, which may
be required for secondary binding of miR-122 to the 5’UTR.
We postulated that a PNA designed to target the S2 site, is capable of invading the 5’UTR+
- miR-122 complex, displacing miR-122. PNA-S2 was synthesized by Dr. Mihailescu in the Ly
lab at Carnegie Mellon University and designed against the S2 site (Figure 28). This PNA-S2 is
active against the 1a and 2a genotypes, as S1 and S2 are 100% conserved across all genotypes
(Shimakami et al. 2012 B). Additionally, PNA-S2 was labeled by Cy-3, a fluorophore with 550
nm excitation maximum and 570 emission maximum, for monitoring binding to the HCV 5’UTR.
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Figure 28. Proposed binding of 5’-UTR+ seed sequence complementary site S2 with PNA-S2.
Sequences for PNA-S2 as well as PNA-S2 M3 and PNA-S2 sc are shown.

Figure 29. PNA-S2 binding HCV 5’-UTR. Right, 20% Native PAGE stained in ethidium
bromide. Left, Fluorimager 595 visualization at absorbance and emission maximum of 512
and 590, respectively. Shows PNA-S2 binding 5’-UTR+ in increasing ratios. PNA-S2 binds in
a 1:0.8 ratio and binds to the second site at higher concentrations.

Figure 30. PNA-S2 displaces miR-122 from HCV 5’-UTR. 20% Native PAGE stained in
ethidium bromide, showing PNA-S2 invasion of miR-122-5’-UTR+ complex. In a 1:1 RNAmiR:PNA ratio, PNA-S2 is able to completely displace miR-122 from the complex.
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To show the ability of PNA-S2 to bind the 5’UTR+ model, native PAGE was chosen.
Figure 29, right image, shows the ethidium bromide staining. The upper band, increasing in
intensity from lane 3-10, corresponds to PNA-S2 bound to 5’UTR+, its appearance concomitant
with disappearance of the free 5’UTR+ band. Unbound 5’UTR+ is observed as the lower band,
decreasing in intensity, in lanes 1-6. Figure 29, left image, shows the Cy3 monitoring of PNA-S2
binding 5’UTR+. Lanes 2-10 contain increasing ratios of RNA to PNA. Maximum fluorescence
was observed at the 1:0.8 ratio in lane 8. The appearance of an upper band indicates that in lanes
9 and 10, the PNA is capable of binding to both the S2 and the S1 sites.

PNA-S2 Can Invade the 5'UTR+ - miR-122 complex. To investigate the ability of PNA-S2 to
invade the RNA-miRNA complex formed between HCV 5’UTR+ and miR-122, 20% native
PAGE was employed (Figure 30). Several controls were visualized in lanes 1 through 6 to correlate
with experimental results. Controls included free 5’UTR+ (lane 1), free miR-122 (lane 2), bound
5’UTR+ - miR-122 complex (lane 3), and PNA-S2 bound to the 5’UTR+ in 1:0.7, 1:1, and 1:3
ratios in lanes 4 through 6, respectively. Lanes 7 through 10 contained the preformed RNA - miR122 complex to which PNA-S2 was added in 1:0.7, 1:1, 1:2, and 1:3 ratios, respectively. In lane
7, the 1:1 RNA-miRNA complex is still observed and can be compared to band position of the
control in lane 3. However, this complex is no longer observed in lane 8, which contains a 1:1 ratio
of RNA-miRNA:PNA. Furthermore, an increase in free miR-122 is observed in lane 8 with band
position comparable to the position of free miR-122 control in lane 2, indicating the displacement
of miR-122 by PNA-S2. Appearance of upper bands equivalent to control lanes 4 through 6
indicate PNA-S2 binding to 5’UTR+ and forming the 5'UTR+ - PNA-S2 complex. This provides
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evidence that PNA-S2 is able to invade and displace miR-122 from the RNA-miRNA complex in
a 1:1 ratio.

Figure 31. PNAs binding HCV 5’-UTR. Curve fitting of normalized fluorescence intensity at
371 nm. A) Graph displays binding of PNA-S2 to 5’-UTR+ containing a 2-AP substitution with
Kd = 4.3 ± 2.0 nM. B) Binding of control PNA-S2 M3, PNA-S2 M3mod, and PNA-S2 sc. C)
Binding of PNA-S2mod with Kd = 65.7 ± 4.9 nM.

Affinity of PNA-S2 for HCV 5'UTR. To determine the dissociation constant (Kd) of the 5'UTR+
- PNA-S2 complex, a 2-aminopurine (2AP) substitution was made in the S2 binding site of the
HCV 5'UTR+ RNA (5'UTR+2AP). The 2AP nucleotide is a fluorescent analogue of guonosine
and adenosine that is sensitive to local environment (Jean and Hall 2001) and whose steady-state
fluorescence can be monitored at 371 nm. Steady-state fluorescence intensity of 2AP is at its
maximum when the fluorophore is inserted in single stranded RNA/DNA, while upon WatsonCrick base pairing between 2AP and uracil/thymine, stacking interactions of nearby bases as a
duplex is formed will lead to the quenching of its steady-state fluorescence intensity. This data can
be used to obtain the Kd if normalized fluorescence intensity is plotted against the concentration
of aliquoted sample and curve fit (Materials and Methods).
Fluorescence experiments were performed by titrating PNA-S2 into a sample containing
5'UTR+. A low Kd was expected as the PNA-S2 binds tight enough to displace miR-122. Curve
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fitting the resulting data (Figure 31A) resulted in a Kd of 4.3 ± 2.0 nM, displaying PNA-S2s high
affinity and tight binding to the 5’UTR+.

Figure 32. Nucleic acid and PNA structures. Chemical structures of DNA/RNA, PNA, PNA
with guanidine substitution at α carbon, PNA with miniPEG substitution at γ carbon, and PNA
with guanidine substitution at γ carbon and structure of a locked nucleic acid.

A negative control fluorescence experiment was performed

using a PNA sequence

containing three mutations in the S2 binding site of PNA-S2 (PNA-S2 M3). Seed sequence
conservation is required for efficient target recognition and binding of miR-122, the PNA should
therefore also display required conservation of the GGAGTG seed sequence to bind its target
sequence, CACUCC. Mutations in the conserved S2 binding sequence should therefore prevent
binding of PNA-S2-M3 to 5’UTR+. Figure 28 depicts the M3 mutant in red with the three
mutations to inhibit binding highlighted in blue, and the complimentary 5’UTR+ sequence shown
above in black. Using native PAGE, we demonastrated that PNA-S2 mutant was unable to bind to
the 5’UTR+ (data not shown). Steady-state fluorescence spectrocopy experiments using PNA-S2M3 were then performed (Figure 31B), the normalized fluroescence intensity at 371 nm is reduced
to 0.8. This loss of fluorescence is minimal compared to PNA-S2 binding, where the normalized
fluorescence intensity drops to below 0.1.

91

A next generation of PNAs were produce to increase water solubility where miniPEG
substitutions were made to the γ carbon of the PNA backbone as shown in figure 32. PNA-S2 as
well as PNA-S2 M3 both contained alternating miniPEG and regular PNA monomers, however,
to increase cell permeability, a guanidine group (Figure 32) was added to the γ position of some
monomers. The synthesized PNAs then alternated between miniPEG and guanidine substituted
monomers and lacked the CY3 fluorophore. PNA-S2 with these modifications (PNA-S2mod) was
synthesized in the Ly lab and the fluorescence experiments performed on PNA-S2 were repeated
using PNA-S2mod (Figure 31C). The Kd obtained for the modified PNA-S2 mod was 65.7 ± 4.9 nM,
much larger than that of the original PNA-S2, yet, still in the low nM range. The higher Kd may
be, in part, due to the positive charge of the guanidino group leading to non-specific interactions
with the negatively charged phosphodiester backbone of the RNA.
Negative control fluorescence experiments were performed with PNA-S2 M3mod sequence
and a second control with modifications in which all the nucleotides less four of them, were
scrambled (PNA-S2 sc); sequence is show in in figure 28 with the unchanged nucleotides
highlighted in orange. Normalized fluorescence intensity at 371 nm plotted against PNA
concentration (Figure 31B). The steady-state fluorescence intensity dropped to 0.8 and 0.9,
comprable to the first PNA-S2 M3 signal, which was reduced to 0.8. Steady-state fluorescence
intensity at 371 nm for PNA-S2 sc remained unchanged in both trials with intensity around 1.0.
PNA-S2 M3 and PNA-S2 M3mod may form non-specific interactions, though overall do not bind,
whereas PNA-S2 sc does not appear to bind to 5’UTR+ at all. These results indicate that the three
controls used bind minimially to 5’UTR+ and display the importance of the conserved seed
sequence in miR-122 and PNA sequences.
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Conclusions. Data and observations discussed, support the hypothesis that miR-122 is capable of
binding the S1 and S2 site of the 5’UTR+ model and that PNA-S2 binds to 5’UTR+ most
effectively in a 1:0.7 ratio of RNA:PNA. It was shown that PNA-S2 is able to invade and displace
miR-122 from the RNA-miRNA complex best in a 1:1 ratio of RNA-miRNA:PNA. Furthermore,
the Kd of 5'UTR+ - PNA-S2 complex was determined to be 4.3 ± 2.0 nM indicating tight binding
and affinity of the PNA for the S2 site of HCV RNA. Kd of the modified PNA-S2 was shown to
be 65.7 ± 4.9 nM with lower affinity for 5’UTR+ than the previous generation of PNA, however,
PNA-S2mod still displays tight binding in low nM range. Three negative controls were used,
showing minimal binding to 5’UTR+ and thus displaying importance in conservation of the seed
sequence. Overall, this data exhibits the potency of PNA-S2 in targeting the HCV 5’UTR and its
promise as an effective antiviral option for HCV infected persons
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Materials and Methods
Sequence Synthesis. The first 46 nucleotides of the HCV RNA 5' untranslated region (5'UTR+)
of genotype 2a, was synthesized by Dharmacon Inc. A fluorescent analogue (5'UTR+2AP)
containing a 2 aminopurine substitution and miR-122 were synthesized by Dharmacon Inc. as well.
All PNAs used were synthesized by the Ly lab at Carnegie Mellon University.

15% and 20% Native Polyacrylamide Gel Electrophoresis. HCV RNA samples (in 10 mM
cacodylic acid, 10 mM NaCl, and 150 mM KCl) were denatured in boiling water for 3 minutes
followed by immediate cooling in dry ice and ethanol for 7 minutes. Quick cooling using this
method prevents RNA strands from aggregating and forces the RNA to fold on itself, forming the
proper stem loop containing structure. miR-122 was then added to the HCV RNA and incubated
at room temperature for 30 minutes, followed by addition of PNA-S2 and incubation at 37 °C for
30 minutes. Native polyacrylamide gel electrophoresis (PAGE) was run at 60 V at 4°C for
approximately 8 and 12 hours for 15% and 20% gels, respectively, followed by ethidium bromide
staining and visualization.

PNA Invasion: 20% Polyacrylamide Gel Electrophoresis. HCV RNA samples (in 10 mM
cacodylic acid, 10 mM NaCl, and 150 mM KCl) were denatured in boiling water for 3 minutes
followed by immediate cooling in dry ice and ethanol for 7 minutes. Samples were incubated at
room temperature with miR-122, allowing for the formation of the RNA - miR-122 complex.
PNA-S2 was then introduced to the samples and incubated at 37°C for 30 min. Native PAGE was
run at 60 volts and 4 °C for 12 hours, followed by visualization using a Molecular Dynamics
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Fluorimager 595, exciting the Cy3 fluorophore on PNA-S2 at 512 nm and observing the emission
at 590 nm. Afterward, ethidium bromide staining and visualization was also used.

Steady-State Fluorescence Spectroscopy of HCV RNA and PNAs. A 2-aminopurine (2AP)
substitution was made in the S2 binding site of the HCV 5'UTR+ RNA (5'UTR+2AP).
Fluorescence experiments were run at 25 °C ( in salt buffer containing 10 mM cacodylic acid, 10
mM NaCl, and 150 mM KCl). 5'UTR+2AP RNA samples were denatured in boiling water for 3
minutes followed by immediate cooling in dry ice and ethanol for 7 minutes. 200 nM 5'UTR+2AP
was added to the Horiba Fluoromax 3 fluorometer and upon equilibration of steady-state
fluorescence signal, emission at 371 nm was recorded. 50 nM increments of PNA-S2, were titrated
and allowed to reach equilibrium of steady-state fluorescence signal between aliquots, this process
being repeated until the fluorescence signal plateaued. This data was then corrected by running the
experiment in the absence of 5’UTR+ and subtracting the emission at 371 nm of the free PNA-S2
from the fluorescence signal observed with PNA-S2 - 5’UTR+ complex. For control PNAs, 150
nM RNA concentrations were used with 15 nM increments of control PNA. Experiments were
performed in triplicate, intensity was normalized for each experiment and plotted as a function of
the peptide or protein concentration and fit to:
𝐼𝐼

𝐹𝐹 = 1 + �𝐼𝐼𝐵𝐵 − 1� ×
𝐹𝐹

(𝐾𝐾𝑑𝑑 +[𝑃𝑃]𝑡𝑡 +[𝑅𝑅𝑅𝑅𝑅𝑅]𝑡𝑡 )−�(𝐾𝐾𝑑𝑑 +[𝑃𝑃]𝑡𝑡 +[𝑅𝑅𝑅𝑅𝑅𝑅]𝑡𝑡 )2 −4x[𝑃𝑃]𝑡𝑡 ×[𝑅𝑅𝑅𝑅𝑅𝑅]𝑡𝑡
2×[𝑅𝑅𝑅𝑅𝑅𝑅]𝑡𝑡

where IF and IB represent steady-state fluorescence intensities of free and bound RNA, respectively.
[RNA]t is the total fixed RNA concentration and [P]t is the total protein concentration. The proteinRNA complex dissociation constant, Kd, was determined for each experiment by fitting binding
curves with Equation 4. Reported Kd represents an average of the three Kd values and standard
deviation from the average fit reported as error
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